Non-selective monoamine reuptake inhibitors

MRI_NONSEL

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Medicine purchases: ATC — N06AA 1 out of 7 registries used, show all original rules.	20187
4. Check minimum number of events Min. number of events 3	20187
5. Include endpoints None	20187
6. Filter based on genotype QC (FinnGen only)	19659

Control definitions (FinnGen only)

Control exclude: ANTIDEPRESSANTS

Extra metadata

First used in FinnGen datafreeze: DF2

NAME	MRI_NONSEL
CONTROL_EXCLUDE	ANTIDEPRESSANTS
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC	N06AA
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Non-selective monoamine reuptake inhibitors based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	19659	12877	6782
Unadjusted period prevalence (%)	4.06	4.57	3.11
Median age at first event (years)	48.13	47.33	49.65

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
20186: Matched controls
194514

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

37.1

323.3

206

IFB01

NOMESCO Finland

Electroconvulsive Therapy (ECT)

70.4

323.3

181

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.9

323.0

5866

34835

R11

ICD-10 Finland

Nausea and vomiting

2.7

321.1

1850

6909

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.6

319.4

2104

8401

F33.01

ICD-10 Finland

Recurrent depression, mild episode of somatic syndrome

109.5

318.7

169

J01MA02

ATC

ciprofloxacin; systemic

1.8

318.6

7880

51364

M70.6

ICD-10 Finland

Trochanteric bursitis

2.2

318.0

3051

14395

N05AC01

ATC

periciazine; systemic

28.1

316.6

219

P01AB01

ATC

metronidazole; oral, rectal

1.8

316.3

8116

53442

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

14.5

315.1

290

195

F33.0

ICD-10 Finland

Recurrent depressive disorder, current episode mild

35.3

314.4

203

SPAT1234

SPAT

Support of social functional capacity

3.5

313.8

1145

3280

M25.5

ICD-10 Finland

Pain in joint

1.8

313.6

6422

39521

2961E

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,VAIKEA-ASTEINEN+PSYKOOT PIIRTEI]

43.4

313.3

192

M03AX01

ATC

botulinum toxin; parenteral

8.8

312.2

401

447

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.8

311.6

7938

52097

N03AF02

ATC

oxcarbazepine; oral

4.4

311.5

818

1854

103

Kela drug reimbursment

Diabetes, insulin-treated

1.9

309.0

5508

32430

F42.1

ICD-10 Finland

Predominantly compulsive acts [obsessional rituals]

70.1

308.8

173

R52.9

ICD-10 Finland

Pain, unspecified

2.5

307.8

2189

9056

N06CA01

ATC

amitriptyline and psycholeptics; systemic

9.4

307.7

4730

6144

N02CC06

ATC

eletriptan; oral

5.0

307.7

993

2001

P15

ICPC

Chronic alcohol abuse

7.8

307.7

636

806

P03

ICPC

Feeling depressed

10.5

307.7

2355

2407

P99

ICPC

Psychological disorders other

15.4

307.7

877

573

M48.0

ICD-10 Finland

Spinal stenosis

2.8

307.7

3148

11908

A02BA02

ATC

ranitidine; systemic

2.8

307.7

5118

20763

M01AC06

ATC

meloxicam; systemic, rectal

1.8

307.7

7680

49113

N02CC04

ATC

rizatriptan; oral

3.5

307.7

1418

4100

G43.9

ICD-10 Finland

Migraine, unspecified

4.3

307.7

1450

3454

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.9

307.7

6391

38042

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

22.7

307.7

267

115

N06BA04

ATC

methylphenidate; oral

10.4

307.7

412

390

F10.24

ICD-10 Finland

Alcohol depence active use

16.6

307.7

426

253

R03AC02

ATC

salbutamol; inhalant

2.0

307.7

11262

75791

J02AC01

ATC

fluconazole; systemic

1.8

307.7

8186

52967

2961C

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,KESKIVAIKEA]

46.8

307.7

358

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

19.3

307.7

422

215

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

3.0

307.7

3833

14075

N05BE01

ATC

buspirone; oral

56.7

307.7

1716

318

SPAT1240

SPAT

Therapeutic discussion

6.3

307.7

2563

4422

C07AA05

ATC

propranolol; systemic

4.2

307.7

5763

17068

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.0

307.7

5182

28285

M54.5

ICD-10 Finland

Low back pain

2.3

307.7

7930

42852

M01AX17

ATC

nimesulide; oral

2.1

307.7

5532

29423

F31.5

ICD-10 Finland

Bipolar affective disorder, current episode severe depression with psychotic symptoms

57.4

307.7

189

M03BX01

ATC

baclofen; systemic

7.7

307.7

564

723

P29

ICPC

Psychological sympt/compl other

7.6

307.7

1642

2242

IGY02

NOMESCO Finland

Psychiatric monitoring contact

18.3

307.7

652

355

AA400

NOMESCO Finland

Electroconvulsive therapy

128.5

307.7

341

N05AX12

ATC

aripiprazole; systemic

29.4

307.7

1404

493

R52.2

ICD-10 Finland

Other chronic pain

7.0

307.7

1333

1939

J45.9

ICD-10 Finland

Asthma, unspecified

2.2

307.7

4162

20161

H03AA01

ATC

levothyroxine sodium; systemic

2.0

307.7

5119

28558

N05AB01

ATC

dixyrazine; systemic

26.6

307.7

604

225

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

21.7

307.7

508

231

G44.2

ICD-10 Finland

Tension-type headache

2.9

307.7

3331

12552

Z2446

NOMESCO Finland

Social worker

3.7

307.7

1451

3937

N05AH03

ATC

olanzapine; systemic

17.7

307.7

2534

1562

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

9.3

307.7

2207

2541

F61.0

ICD-10 Finland

Mixed personality disorders

69.6

307.7

731

105

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

103.0

307.7

521

A02BA04

ATC

nizatidine; systemic

3.2

307.7

2027

6642

N06AX22

ATC

agomelatine; oral

96.2

307.7

722

N02BF01

ATC

gabapentin; oral

4.0

307.7

2335

6114

M79.0

ICD-10 Finland

Rheumatism, unspecified

13.2

307.7

1954

1572

N02AX02

ATC

tramadol; systemic, rectal

3.2

307.7

11277

55248

N06AX11

ATC

mirtazapine; oral

13.5

307.7

11651

17919

G43.3

ICD-10 Finland

Complicated migraine

11.1

307.7

619

553

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

11.9

307.7

605

505

IDY03

NOMESCO Finland

Systematic individual therapy, cognitive-behavioural

8.6

307.7

484

557

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

3.2

307.7

1442

4581

N06AG02

ATC

moclobemide; oral

41.2

307.7

2136

557

J01EA01

ATC

trimethoprim; systemic

1.9

307.7

5658

32966

F13.1

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use

94.7

307.7

214

N05AN01

ATC

lithium; oral

30.4

307.7

1084

362

2968A

ICD-9 Finland

Affective psychoses, Manic-depressive psychosis, other and unspecified

28.3

307.7

499

174

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

32.6

307.7

674

206

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

36.8

307.7

1025

282

F60.7

ICD-10 Finland

Dependent personality disorder

67.2

307.7

207

F41.1

ICD-10 Finland

Generalized anxiety disorder

16.6

307.7

1315

812

9694A

ICD-9 Finland

Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers

20.7

307.7

271

128

N05AD03

ATC

melperone; systemic

12.8

307.7

558

432

R06.0

ICD-10 Finland

Dyspnoea

2.2

307.7

5919

30704

N05BA05

ATC

potassium clorazepate; oral

21.8

307.7

398

179

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

24.3

307.7

518

211

P01

ICPC

Feeling anxious/nervous/tense

6.5

307.7

2434

4009

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

9.2

307.7

484

517

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

17.6

307.7

293

163

F32

ICD-10 Finland

Depressive episode

16.7

307.7

1317

811

2961D

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,VAIKEA-ASTEINEN]

49.7

307.7

285

F41.00

ICD-10 Finland

Moderate panic disorder

35.7

307.7

442

122

N05CD08

ATC

midazolam; nasal, systemic

8.1

307.7

798

980

R42

ICD-10 Finland

Dizziness and giddiness

2.0

307.7

4790

26434

N04AA02

ATC

biperiden; systemic

13.9

307.7

741

532

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

11.5

307.7

373

318

N05AC02

ATC

thioridazine; oral

16.4

307.7

852

520

G04BD04

ATC

oxybutynin; oral, transdermal

3.4

307.7

1367

4032

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.2

307.7

3846

18669

N05BA01

ATC

diazepam; systemic, rectal

9.7

307.7

5858

7903

SPAT1254

SPAT

Administration of medicine

2.3

307.7

3024

13754

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

114.3

307.7

643

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

34.6

307.7

1101

324

N03AX11

ATC

topiramate; oral

15.1

307.7

1180

794

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

12.0

307.7

466

381

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

17.1

307.7

347

199

N06AX12

ATC

bupropion; oral

44.6

307.7

2111

508

F42.2

ICD-10 Finland

Mixed obsessional thoughts and acts

77.2

307.7

214

N06AX18

ATC

reboxetine; oral

114.4

307.7

577

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

60.4

307.7

870

145

N02CC07

ATC

frovatriptan; oral

4.3

307.7

1012

2354

N06AB10

ATC

escitalopram; oral

17.8

307.7

5594

4102

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.3

307.7

8159

43913

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

4.8

307.7

1466

3146

SPAT1307

SPAT

Psychosocial counselling and guidance

5.7

307.7

1054

1851

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

3.2

307.7

2071

6688

A02BC05

ATC

esomeprazole; systemic

2.2

307.7

9140

53386

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

18.3

307.7

697

379

N02AC04

ATC

dextropropoxyphene; oral

4.9

307.7

1271

2609

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

60.2

307.7

204

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

117.1

307.7

590

N05AA01

ATC

chlorpromazine; systemic, rectal

18.5

307.7

567

303

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.8

307.7

2346

8583

F60.9

ICD-10 Finland

Personality disorder, unspecified

48.8

307.7

538

109

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

10.8

307.7

2519

2534

Z76.0

ICD-10 Finland

Issue of repeat prescription

2.2

307.7

4770

23760

AA1AD

NOMESCO Finland

CT of head and brain

2.1

307.7

5604

30628

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

11.5

307.7

2141

1983

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

80.4

307.7

825

103

F31.31

ICD-10 Finland

Bipolar disorder depressive episode with somatic syndrome

96.1

307.7

217

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.4

307.7

3261

14592

N06AA06

ATC

trimipramine; systemic

105.9

307.7

2673

280

N06AA04

ATC

clomipramine; systemic

163.2

307.7

2137

141

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

106.3

307.7

400

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

3.5

307.7

2300

6877

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

75.4

307.7

812

108

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

208.3

307.7

2163

112

N05BA06

ATC

lorazepam; systemic, sublingual

11.2

307.7

2107

2003

T36

ICD-10 Finland

Poisoning by systemic antibiotics

22.9

307.7

1824

839

M03BC01

ATC

orphenadrine (citrate); systemic

2.3

307.7

5004

24606

N02AA05

ATC

oxycodone; systemic

2.5

307.7

4022

17758

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

16.5

307.7

302

179

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

109.2

307.7

1675

161

N05CF02

ATC

zolpidem; oral

5.2

307.7

5330

12644

V03AA01, ,

ATC

15.5

307.7

580

371

R53

ICD-10 Finland

Malaise and fatigue

2.6

307.7

5222

23299

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

223.3

307.7

431

F33

ICD-10 Finland

Recurrent depressive disorder

54.6

307.7

508

P76

ICPC

Depressive disorder

24.5

307.7

1847

795

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.2

307.7

3609

17249

F41.0

ICD-10 Finland

Panic disorder [episodic paroxysmal anxiety]

12.4

307.7

414

328

N05AA02

ATC

levomepromazine; systemic

32.9

307.7

2586

864

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

38.3

307.7

336

N04BC05

ATC

pramipexole; oral

3.5

307.7

1969

5843

188

Kela drug reimbursment

Psychosis requiring demanding treatment

18.1

307.7

355

192

N06AA12

ATC

doxepin; systemic

88.7

307.7

6570

1052

M01AB05

ATC

diclofenac; systemic, rectal

1.9

307.7

13396

100372

N05AH04

ATC

quetiapine; oral

16.4

307.7

7069

6172

N05BA12

ATC

alprazolam; oral

12.0

307.7

4155

4100

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

65.5

307.7

664

101

N03AX12

ATC

[U] gabapentin; oral

5.4

307.7

5994

14083

R51.80

ICD-10 Finland

Headache

3.0

307.7

3725

13454

R52.1

ICD-10 Finland

Chronic intractable pain

15.5

307.7

396

251

L03

ICPC

Low back symptom/complaint

2.1

307.7

5836

31029

M01AE02

ATC

naproxen; oral, rectal

2.0

307.7

11731

78841

F31.8

ICD-10 Finland

Other bipolar affective disorders

41.9

307.7

554

131

F32.1

ICD-10 Finland

Moderate depressive episode

15.3

307.7

1407

949

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

16.6

307.7

367

217

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

15.3

307.7

820

536

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

154.5

307.7

962

P74

ICPC

Anxiety disorder/anxiety state

14.2

307.7

988

703

A06AC01

ATC

ispaghula (psylla seeds); oral

2.8

307.7

6798

29685

F40.1

ICD-10 Finland

Social phobias

25.9

307.7

514

196

M03BX02

ATC

tizanidine; oral

2.1

307.7

12943

89848

P06

ICPC

Sleep disturbance

3.7

307.7

2722

7847

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.9

307.7

2098

7564

N02AJ06

ATC

codeine and paracetamol; systemic

1.9

307.7

8485

53325

A02BC03

ATC

lansoprazole; oral

2.5

307.7

7071

34645

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

73.7

307.7

773

105

F51.0

ICD-10 Finland

Nonorganic insomnia

5.2

307.7

4204

9286

F34.1

ICD-10 Finland

Dysthymia

72.7

307.7

1528

219

A03FA01

ATC

metoclopramide; systemic, rectal

2.2

307.7

5142

25945

M01AH02

ATC

rofecoxib; oral

2.5

307.7

3231

13648

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

7.0

307.7

1856

2757

N06AB04

ATC

citalopram; systemic

27.4

307.7

8653

5191

N05AX08

ATC

risperidone; systemic

7.7

307.7

2733

3874

E66.01

ICD-10 Finland

Obesity due to excess calories

2.8

307.7

1858

6813

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

20.4

307.7

398

192

3018D

ICD-9 Finland

Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]

39.2

307.7

277

N05AF03

ATC

chlorprothixene; systemic

37.3

307.7

1536

428

IGY02, ,

SPAT

18.4

307.7

302

160

N06AA10

ATC

nortriptyline; systemic

44.9

307.7

2260

545

F41.09

ICD-10 Finland

UNS Panic Syndrome

17.6

307.7

733

416

M54.4

ICD-10 Finland

Lumbago with sciatica

2.6

307.7

4324

18381

N06AX21

ATC

duloxetine; oral

23.5

307.7

5142

2789

N05AL01

ATC

sulpiride; systemic

38.8

307.7

778

201

F13.25

ICD-10 Finland

Addiction caused by sedative and hypnotic continuous use

173.2

307.7

231

R07.4

ICD-10 Finland

Chest pain, unspecified

2.0

307.7

5995

33519

F31

ICD-10 Finland

Bipolar affective disorder

36.7

307.7

381

102

N06AA09

ATC

amitriptyline; systemic

71.1

307.7

12106

4017

C03CA01

ATC

furosemide; systemic

2.1

307.7

6634

37214

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

4.9

307.7

868

1785

Z2445

NOMESCO Finland

Psychologist

6.2

307.7

852

1372

3007

Kela drug reimbursment

Erenumab and fremanezumab

11.9

307.7

442

365

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

22.5

307.7

387

169

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

3.0

307.7

2437

8560

M02AA07

ATC

piroxicam; topical

1.9

307.7

7883

48906

A02BC02

ATC

pantoprazole; systemic

2.3

307.7

14475

102401

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

31.5

307.7

357

111

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

103.6

307.7

2196

229

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

45.7

307.7

491

106

M01AE03

ATC

ketoprofen; systemic, rectal

2.4

307.7

8864

48239

A01AB09

ATC

miconazole; local oral

2.6

307.7

2082

8104

N06AB08

ATC

fluvoxamine; oral

51.5

307.7

1245

248

N03AX09

ATC

lamotrigine; oral

27.4

307.7

2129

834

M79.7

ICD-10 Finland

Fibromyalgia

13.8

307.7

1658

1254

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

59.5

307.7

2696

503

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

5.4

307.7

4985

11147

G47.3

ICD-10 Finland

Sleep apnoea

2.3

307.7

4646

22483

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

60.1

307.7

277

M01AH01

ATC

celecoxib; oral

2.5

307.7

4549

20497

P72

ICPC

Schizophrenia

9.9

307.7

484

480

30041

ICD-8 Finland

Neuroses, Depressiva

9.4

307.7

411

429

A03FA02

ATC

cisapride; oral, rectal

3.3

307.7

2046

6431

F20.9

ICD-10 Finland

Schizophrenia, unspecified

10.5

307.7

614

579

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

25.1

307.7

2725

1203

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

31.9

307.7

460

142

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

13.6

307.7

1140

853

N05CD02

ATC

nitrazepam; oral

15.1

307.7

863

573

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

28.0

307.7

1367

504

N03AE01

ATC

clonazepam; systemic

13.1

307.7

2950

2518

K59.0

ICD-10 Finland

Constipation

3.5

307.7

1423

4103

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

216.3

307.7

244

N02BE01

ATC

paracetamol; systemic, rectal

2.4

307.7

17905

149553

L28

ICPC

Limited function/disability (L)

2.5

307.7

4094

18037

N05BA02

ATC

chlordiazepoxide; systemic

22.5

307.7

1106

499

N06AX17

ATC

milnacipran; oral

138.4

307.7

518

N06AX16

ATC

venlafaxine; oral

45.9

307.7

6154

1839

IGY99

NOMESCO Finland

Other psychiatric treatment contact

23.0

307.7

425

182

C07AB07

ATC

bisoprolol; oral

2.1

307.7

10530

66921

P18

ICPC

Medication abuse

31.0

307.7

242

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

23.7

307.7

919

390

F60.8

ICD-10 Finland

Other specific personality disorders

41.2

307.7

203

N06AX05

ATC

trazodone; oral

84.9

307.7

1296

157

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

5.3

307.7

727

1368

A04

ICPC

Weakness/tiredness general

2.4

307.7

2848

12702

N07BB01

ATC

disulfiram; oral

12.2

307.7

1290

1084

N06AB05

ATC

paroxetine; oral

35.5

307.7

2428

746

F43.1

ICD-10 Finland

Post-traumatic stress disorder

9.7

307.7

500

509

3018X

ICD-9 Finland

Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]

25.9

307.7

286

108

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

3.0

307.7

1669

5648

N06AB03

ATC

fluoxetine; oral

29.2

307.7

5446

2431

N02BF02

ATC

pregabalin; oral

5.5

307.7

1841

3458

N02CC03

ATC

zolmitriptan; nasal, oral

3.6

307.7

1352

3851

A06AD11

ATC

lactulose; oral

3.9

307.7

4449

13165

N06AX03

ATC

mianserin; oral

47.8

307.7

2689

624

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

16.5

307.7

487

291

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

12.9

307.7

472

361

N03AG01

ATC

valproic acid; systemic, rectal

11.3

307.7

2522

2417

N06AB06

ATC

sertraline; oral

36.6

307.7

4326

1440

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

3.7

307.7

1160

3156

N05AH02

ATC

clozapine; systemic

17.8

307.7

628

350

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.3

307.7

6782

34708

F10.25

ICD-10 Finland

Alcohol dependence continuous use

13.6

307.7

509

370

C07AB02

ATC

metoprolol; systemic

2.1

307.7

4403

23261

A03CA02

ATC

clidinium and psycholeptics; oral

4.2

307.7

1758

4331

A10BA02

ATC

metformin; oral

1.9

307.7

5849

33973

N05AB03

ATC

perphenazine; systemic, rectal

23.2

307.7

1808

823

N06AA22, ,

ATC

142.3

307.7

671

N02CD01

ATC

erenumab; parenteral

13.6

307.7

318

228

A01

ICPC

Pain general/multiple sites

3.3

307.7

2365

7522

N05AE04

ATC

ziprasidone; systemic

52.1

307.7

198

N05BA04

ATC

oxazepam; oral

9.0

307.7

9302

16853

M01AG02

ATC

tolfenamic acid; oral, rectal

2.5

307.7

3605

15483

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.9

307.7

5952

34477

N05CD07

ATC

temazepam; oral

12.7

307.7

6204

6565

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

9.9

307.7

542

541

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

179.3

307.7

239

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

23.5

307.7

381

159

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

2.0

307.7

5066

27934

F32.9

ICD-10 Finland

Depressive episode, unspecified

23.6

307.7

4673

2449

IHZ05, ,

SPAT

7.3

307.7

560

756

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

3.2

307.7

3221

10961

F39

ICD-10 Finland

Unspecified mood [affective] disorder

15.7

307.7

383

240

SPAT1243

SPAT

Psychiatric/psychological examination

11.0

307.7

520

467

N05CF01

ATC

zopiclone; oral

6.8

307.7

11023

29230

F33.8

ICD-10 Finland

Other recurrent depressive disorders

111.8

307.7

252

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

20.9

307.7

622

296

K59.09

ICD-10 Finland

Constipation, unspecified

3.2

307.7

1592

5055

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

2.0

307.7

5874

33411

A02BC01

ATC

omeprazole; systemic

2.5

307.7

6599

31746

N05AD01

ATC

haloperidol; systemic

6.9

307.7

995

1459

N03AX16

ATC

[U] pregabalin

5.4

307.7

8369

22545

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

8.2

307.7

2555

3368

N06AX26

ATC

vortioxetine; oral

46.8

307.7

1950

443

R06AE07

ATC

cetirizine; oral

1.8

307.7

8726

58346

J01DA01

ATC

[U] cefalexin

1.9

307.7

12609

91911

N06AA21

ATC

maprotiline; systemic

126.5

307.7

195

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.6

307.7

2691

10969

F10.20

ICD-10 Finland

Alcohol dependence currently independent

20.2

307.7

682

336

H02AB06

ATC

prednisolone; systemic

1.9

307.7

9951

66277

F60.5

ICD-10 Finland

Anankastic personality disorder

27.1

307.7

280

101

F61

ICD-10 Finland

Mixed and other personality disorders

59.5

307.7

226

F99

ICD-10 Finland

Mental disorder, not otherwise specified

11.9

307.7

508

420

F29

ICD-10 Finland

Unspecified nonorganic psychosis

10.9

307.7

996

926

F32.8

ICD-10 Finland

Other depressive episodes

21.4

307.7

403

185

N05AF01

ATC

flupentixol; systemic

33.7

307.7

852

254

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

18.0

307.7

3403

2165

N02CC05

ATC

almotriptan; oral

4.2

307.7

1021

2423

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

3.1

307.7

1588

5186

M03BC51

ATC

orphenadrine, combinations; systemic

2.1

307.7

5979

32204

M01AB55

ATC

diclofenac, combinations; oral

3.2

307.7

1867

5977

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

2.3

307.7

10065

58499

ZY010

NOMESCO Finland

Hospital outpatient

5.5

307.7

1153

2101

N03AF01

ATC

carbamazepine; oral, rectal

5.9

307.7

1857

3311

M79.6

ICD-10 Finland

Pain in limb

2.0

307.7

8836

54735

F41.8

ICD-10 Finland

Other specified anxiety disorders

7.4

307.7

519

689

R03BB04

ATC

tiotropium bromide; inhalant

2.5

307.4

2186

9043

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.1

305.7

3425

17154

R02

ICPC

Shortness of breath/dyspnoea

2.3

303.9

2732

12531

UJF32

NOMESCO Finland

Coloscopy

1.9

303.8

5431

31978

J01FF01

ATC

clindamycin; systemic

1.9

302.1

5549

32943

E66.8

ICD-10 Finland

Other obesity

3.3

301.1

1191

3590

EBA00

NOMESCO Finland

Extraction of tooth

1.8

299.4

6621

41573

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.1

298.7

3429

17319

T90

ICPC

Diabetes non-insulin dependent

1.9

297.7

4837

27587

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

18.9

297.3

240

124

N05AB02

ATC

fluphenazine; systemic

17.3

297.3

250

141

N02CD03

ATC

fremanezumab; systemic

12.1

297.0

304

245

L17

ICPC

Foot/toe symptom/complaint

1.8

295.9

5735

34580

A28

ICPC

Limited function/disability NOS

2.1

295.9

3377

17014

E0000UV, ,

ATC

1.7

292.2

8132

54447

Z01.8

ICD-10 Finland

Other specified special examinations

1.9

290.6

4592

25923

SPAT1216

SPAT

Assessment of functional ability

2.1

288.9

3180

15791

F32.01

ICD-10 Finland

Mild depressive episode with somatic syndrome

16.6

288.8

248

146

F90.0

ICD-10 Finland

Disturbance of activity and attention

8.3

288.6

388

458

Z3226

NOMESCO Finland

Physiotherapist

2.0

288.3

3651

19094

F10.09

ICD-10 Finland

Alcohol intoxication UNS

6.8

287.9

462

668

ZY000

NOMESCO Finland

Hospital inpatient

12.6

287.6

287

222

N05CD05

ATC

triazolam; oral, sublingual

7.4

287.5

427

567

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

3.2

286.0

1244

3970

N05AF05

ATC

zuclopenthixol; systemic

10.9

285.0

312

279

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.0

283.9

3832

20486

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.7

283.8

8957

61925

F41.3

ICD-10 Finland

Other mixed anxiety disorders

12.7

283.4

282

217

A02BX02

ATC

sucralfate; oral

3.5

283.0

1036

2971

ABD32

NOMESCO Finland

Implantation of temporary spinal stimulation device

18.6

281.8

229

120

F51.9

ICD-10 Finland

Nonorganic sleep disorder, unspecified

6.4

280.3

474

724

R56.8

ICD-10 Finland

Other and unspecified convulsions

3.5

279.3

1040

3015

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

29.0

279.2

191

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

2.0

277.6

4003

21873

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.1

277.6

3256

16536

SPAT1301

SPAT

No procedures

1.8

276.8

6073

37860

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

11.3

276.3

295

254

G04BD07

ATC

tolterodine; oral

3.2

275.9

1173

3691

P16

ICPC

Acute alcohol abuse

9.1

274.4

343

369

M01AE51

ATC

ibuprofen, combinations; systemic

5.7

273.6

524

905

3004A

ICD-9 Finland

Neurotic disorders, Neurotic depression

22.0

272.7

206

9690A

ICD-9 Finland

Poisoning by psychotropic agents, Antidepressants

40.3

272.5

170

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.7

271.9

8815

61153

Z3231

NOMESCO Finland

Registered nurse

1.8

271.0

5268

31644

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.8

270.6

5301

31914

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.7

267.9

8868

61782

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.8

266.5

4847

28504

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

3.5

266.3

978

2809

P80

ICPC

Personality disorder

48.3

265.5

159

UKC02

NOMESCO Finland

Cystoscopy

2.1

265.1

3119

15835

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

24.6

265.0

192

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

2.0

264.5

3442

18121

N01

ICPC

Headache

2.5

263.3

1875

7737

V03AB30, ,

ATC

18.4

263.1

215

114

X61

ICD-10 Finland

Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classified

35.1

263.1

170

F31.20

ICD-10 Finland

Bipolar disorder, manic episode with mood-congruent psychotic symptoms

15.9

261.6

229

140

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.1

260.1

2891

14363

WX110

NOMESCO Finland

Infiltration anesthesia

1.7

260.0

13363

104063

J01AA02

ATC

doxycycline; systemic

1.8

260.0

15590

126770

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.8

258.0

4945

29506

N02CC02

ATC

naratriptan; oral

5.2

257.8

546

1034

F32.0

ICD-10 Finland

Mild depressive episode

6.5

257.5

428

642

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

2.1

256.1

2652

12818

H02AB07

ATC

prednisone; oral

2.1

255.9

2953

14871

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

2.2

255.8

2490

11744

N02CX04, ,

ATC

4.5

255.6

647

1423

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

3.0

254.7

1216

4089

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

30.8

254.6

171

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.8

254.5

1337

4739

SPAT1229

SPAT

Assessment of need for aid

2.5

254.5

1695

6774

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.7

254.3

10457

76668

N05BB01

ATC

hydroxyzine; systemic

2.8

254.1

1375

4951

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

45.3

253.7

154

7290A

ICD-9 Finland

Other disorders of soft tissues, Rheumatism, unspecified and fibrositis

12.6

252.4

252

195

N89

ICPC

Migraine

4.5

250.6

625

1358

L01

ICPC

Neck symptom/complaint

2.0

250.3

3031

15525

F42.0

ICD-10 Finland

Predominantly obsessional thoughts or ruminations

48.2

248.7

149

A07AA02

ATC

nystatin; oral

2.8

248.3

1387

5076

L86

ICPC

Back syndrome with radiating pain

2.8

247.6

1332

4779

G43

ICD-10 Finland

Migraine

3.3

247.4

968

2892

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.7

246.9

6994

46482

X59

ICD-10 Finland

Exposure to unspecified factor

1.9

246.8

3643

19975

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

3.0

246.3

1141

3771

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

2.1

245.8

2751

13681

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.1

244.3

2672

13172

2989X

ICD-9 Finland

Other nonorganic psychoses, Unspecified psychosis

11.3

244.2

261

225

SAA01

NOMESCO Finland

Simple examination of mouth

1.7

242.3

13368

104991

M54.1

ICD-10 Finland

Radiculopathy

3.3

242.1

943

2809

M01AX01

ATC

nabumetone; oral

3.1

241.9

1068

3432

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.6

241.2

1519

5903

S06.0

ICD-10 Finland

Concussion

2.3

240.4

2054

9170

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

34.4

240.0

156

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

3.8

239.7

762

1985

N06AC02, ,

ATC

29.7

238.5

162

K02.1

ICD-10 Finland

Caries of dentine

1.6

238.2

10689

79558

M47.82

ICD-10 Finland

Other spondylosis, cervical region

3.2

237.2

971

2982

M47.9

ICD-10 Finland

Spondylosis, unspecified

3.6

236.9

824

2282

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.8

236.6

4238

24680

N30.0

ICD-10 Finland

Acute cystitis

1.9

236.5

3292

17673

SPAT1263

SPAT

Sampling

1.6

235.9

7842

54152

IGV01

NOMESCO Finland

Psychiatric network contact

21.9

235.1

178

J01FA06

ATC

roxithromycin; oral

1.6

235.1

7822

54012

SPAT1262

SPAT

Handing over of treatment supplies

1.9

234.2

3432

18741

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

4.8

233.8

541

1105

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.2

233.5

2136

9805

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

9.2

232.8

289

308

M79.1

ICD-10 Finland

Myalgia

2.0

232.7

2777

14119

SFA10

NOMESCO Finland

One-surface restoration

1.6

231.6

10103

74474

E000001, ,

ATC

1.9

231.5

3820

21668

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

56.5

230.7

134

F40.01

ICD-10 Finland

Agoraphobia with concomitant panic disorder

56.1

228.7

133

Z08

ICPC

Social welfare problem

7.8

227.4

323

407

Z71.8

ICD-10 Finland

Other specified counselling

1.7

227.4

5601

35688

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.3

227.3

1913

8477

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

12.1

226.6

232

187

G04BD08

ATC

solifenacin; oral

2.6

225.8

1426

5545

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

3.3

224.9

916

2803

J01DB01

ATC

cefalexin; oral

1.8

224.0

16018

133146

M02AA10

ATC

ketoprofen; topical

1.9

223.7

3337

18302

N06AA02

ATC

imipramine; systemic

90.2

223.2

121

B18.2

ICD-10 Finland

Chronic viral hepatitis C

9.6

222.8

266

269

M89.0

ICD-10 Finland

Algoneurodystrophy

8.7

222.5

288

324

R35

ICD-10 Finland

Polyuria

2.7

222.2

1331

5041

G04BD12

ATC

mirabegron; oral

2.1

221.7

2304

11112

F22.0

ICD-10 Finland

Delusional disorder

6.5

220.6

369

557

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.2

220.3

2091

9732

A01AB04

ATC

amphotericin B; local oral

2.9

219.8

1132

3963

D07AA02

ATC

hydrocortisone; topical

2.0

219.4

2605

13200

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

3.1

219.2

984

3190

F21

ICD-10 Finland

Schizotypal disorder

19.4

218.6

174

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

4.1

217.9

612

1457

R05FB02

ATC

cough suppressants and expectorants; systemic

1.6

217.8

7399

51086

N07BC02

ATC

methadone; systemic

22.1

217.5

164

M54.3

ICD-10 Finland

Sciatica

2.6

216.8

1335

5124

F45.0

ICD-10 Finland

Somatization disorder

20.8

216.0

167

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

9.2

216.0

267

283

M01AB51

ATC

indometacin, combinations; oral, rectal

4.1

215.3

611

1466

R01BA52

ATC

pseudoephedrine, combinations; oral

1.7

215.1

5992

39330

Z72.2

ICD-10 Finland

Drug use

26.2

213.3

151

F41.01

ICD-10 Finland

Severe panic disorder

47.7

213.2

128

WX290

NOMESCO Finland

Other blockage of nerve

1.6

212.8

8006

56569

SPAT1260

SPAT

Consultation of another employee

1.9

212.7

3390

18965

H02AB04

ATC

methylprednisolone; systemic

1.9

212.6

3003

16152

F42.9

ICD-10 Finland

Obsessive-compulsive disorder, unspecified

37.4

212.4

135

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.1

212.0

2404

11970

L02

ICPC

Back symptom/complaint

2.2

211.6

1893

8594

R33

ICD-10 Finland

Retention of urine

2.5

210.8

1486

6081

R5140

NOMESCO Finland

Monitoring the use of the aid

2.2

210.8

2059

9684

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

3.3

210.8

817

2424

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.7

210.6

4933

30893

R03BA02

ATC

budesonide; inhalant

1.9

209.2

3441

19432

I10

ICD-10 Finland

Essential (primary) hypertension

1.6

209.0

11844

91909

D12

ICPC

Constipation

3.4

208.7

774

2233

M01AH05

ATC

etoricoxib; oral

1.6

208.6

11882

92294

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.3

208.3

1651

7119

K07.60

ICD-10 Finland

Snapping jaw

2.9

207.8

1035

3556

M96.1

ICD-10 Finland

Postlaminectomy syndrome, not elsewhere classified

9.7

207.4

247

249

R96

ICPC

Asthma

2.2

207.2

1944

8994

T82

ICPC

Obesity

3.3

207.2

808

2406

J01MA12

ATC

levofloxacin; systemic

1.8

206.9

3593

20625

N06AC01, ,

ATC

106.6

206.6

110

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

2.3

206.6

1723

7593

R03DC03

ATC

montelukast; oral

1.9

206.5

3175

17542

IBZ02

NOMESCO Finland

Somatic assessment of psychiatric patient

37.4

206.0

131

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

18.3

205.6

168

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

3.4

204.4

773

2258

AEA00

NOMESCO Finland

Replacement of impulse generator of stimulation device in the nervous system

13.4

204.1

196

142

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

2.9

203.9

1001

3411

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

9.9

203.5

238

234

A02BA03

ATC

famotidine; systemic

3.1

203.4

893

2856

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.7

203.3

1150

4226

Z02.7

ICD-10 Finland

Issue of medical certificate

2.5

203.2

1387

5589

IER02

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, group

18.1

202.1

166

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.8

202.0

3473

19860

F60.0

ICD-10 Finland

Paranoid personality disorder

35.0

200.9

130

J01CA08

ATC

pivmecillinam; oral

1.6

200.1

8061

57628

K59.1

ICD-10 Finland

Functional diarrhoea

2.7

200.0

1117

4077

M54.2

ICD-10 Finland

Cervicalgia

2.3

199.6

1593

6885

IBB02

NOMESCO Finland

Psychiatric evaluation of working capacity and rehabilitation

43.8

199.4

122

F60.6

ICD-10 Finland

Anxious [avoidant] personality disorder

58.7

199.2

115

F25.20

ICD-10 Finland

Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms

18.6

198.4

161

3050A

ICD-9 Finland

Nondependent abuse of drugs, Alcohol abuse

8.5

195.9

257

294

XF400

NOMESCO Finland

ECG with 12 standard connections

1.9

195.9

2908

15862

G47.9

ICD-10 Finland

Sleep disorder, unspecified

4.1

195.9

552

1317

F43.20

ICD-10 Finland

Adaptation disorder with short-term depression

7.0

195.7

305

427

A06AC51

ATC

ispaghula, combinations; oral

2.8

194.2

1040

3713

R01AD09

ATC

mometasone; nasal

1.6

193.9

8316

60175

F11.25

ICD-10 Finland

Relationship caused by opiates continuously used

50.7

193.8

115

D07AC01

ATC

betamethasone; topical

1.6

193.7

6827

47213

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.9

193.6

945

3209

D11

ICPC

Diarrhoea

2.1

193.1

2020

9739

G50.1

ICD-10 Finland

Atypical facial pain

4.5

192.7

481

1045

SPAT1215

SPAT

Assessment of need for medical rehabilitation

3.1

192.6

832

2635

R01AD08

ATC

fluticasone; nasal

1.7

192.3

5309

34573

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.8

191.9

3917

23522

F51

ICD-10 Finland

Nonorganic sleep disorders

3.5

191.7

680

1905

R60.0

ICD-10 Finland

Localized oedema

2.0

191.6

2472

12858

SAA03

NOMESCO Finland

Extended examination of mouth

1.6

191.6

6887

47818

M53.1

ICD-10 Finland

Cervicobrachial syndrome

2.0

191.4

2248

11312

WX308

NOMESCO Finland

Sacral anesthesy

15.6

191.4

169

105

S18

ICPC

Laceration/cut

1.6

191.2

8541

62310

SAA02

NOMESCO Finland

Basic examination of mouth

1.6

191.0

11945

93856

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.1

190.2

2122

10478

D07AB02

ATC

hydrocortisone butyrate; topical

1.6

190.0

5515

36352

SPAT1249

SPAT

Treatment-related counselling outside office

1.6

189.2

7115

49886

E66.00

ICD-10 Finland

Metabolic syndrome

2.7

189.2

1116

4187

F34.9

ICD-10 Finland

Persistent mood [affective] disorder, unspecified

33.4

189.1

124

IHZ04, ,

SPAT

11.2

188.5

203

177

WZC00

NOMESCO Finland

Treatment plan or consultation

1.6

188.4

6617

45650

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.3

188.3

1497

6454

M01AC01

ATC

piroxicam; systemic, rectal

1.9

187.3

2700

14571

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

186.7

9499

71187

N02CA52

ATC

ergotamine, combinations excl. psycholeptics; oral

4.6

186.5

459

986

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

3.0

185.8

857

2818

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.8

185.3

3624

21474

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

3.0

184.9

873

2909

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.7

184.9

4536

28605

IER01

NOMESCO Finland

Psychoeducation, group

25.1

183.7

132

R1250

NOMESCO Finland

Evaluation of functional capability

4.1

183.5

522

1254

P28

ICPC

Limited function/disability (P)

10.6

182.5

204

188

IEY01

NOMESCO Finland

Psychoeducation, individual

24.6

182.4

132

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.7

181.9

4797

30803

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

3.2

181.5

743

2278

R13

ICD-10 Finland

Dysphagia

2.4

181.4

1366

5748

XKC03

NOMESCO Finland

Water cystometry

3.4

180.1

682

1992

R07.3

ICD-10 Finland

Other chest pain

2.1

179.8

1993

9807

P20

ICPC

Memory disturbance

2.0

179.7

2352

12278

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.9

179.6

2552

13693

WZA90

NOMESCO Finland

Other medical or dental certificate

1.7

179.0

4148

25733

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.1

179.0

1961

9608

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

3.6

178.7

623

1725

SPAT1310

SPAT

Counselling related to known health issue

1.6

178.5

5686

38226

3000A

ICD-9 Finland

Neurotic disorders, Anxiety states[TARKEMMIN MÄÄRITTELEMÄTÖN AHDISTUNEISUUSHÄIRIÖ]

19.4

178.3

142

SFA30

NOMESCO Finland

Three-surface restoration

1.5

178.0

7850

56825

P25

ICPC

Phase of life problem adult

3.5

177.8

646

1838

D01

ICPC

Abdominal pain/cramps general

2.0

177.6

2048

10223

Z50.7

ICD-10 Finland

Occupational therapy and vocational rehabilitation, not elsewhere classified

11.3

177.5

189

162

M01AH03

ATC

valdecoxib; oral

2.4

177.0

1337

5632

R03BA01

ATC

beclometasone; inhalant

1.9

176.8

2756

15232

C10AA01

ATC

simvastatin; oral

1.5

176.0

7877

57163

R51

ICD-10 Finland

Headache

2.6

175.7

1049

3956

Z00.0

ICD-10 Finland

General medical examination

1.7

175.6

3552

21213

ZXY01

NOMESCO Finland

Chief Physician, Head of Department or Deputy Chief Physician

19.5

175.1

139

F20.39

ICD-10 Finland

Undifferentiated schizophrenia UNS

14.5

175.0

161

108

F13.20

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent

294.0

174.7

180

R41.0

ICD-10 Finland

Disorientation, unspecified

3.5

174.6

636

1812

P73

ICPC

Affective psychosis

22.5

173.7

130

F20.09

ICD-10 Finland

Paranoid schizophrenia UNS

10.5

173.6

195

181

N05AA03

ATC

promazine; systemic

48.0

173.3

104

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

2.4

172.9

1263

5240

N07BA03

ATC

varenicline; oral

2.9

172.8

878

3045

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

3.6

172.6

586

1594

U04

ICPC

Incontinence urine

2.6

172.6

1051

4002

C05AA08

ATC

fluocortolone; rectal, topical

1.9

172.5

2669

14707

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.9

172.5

2569

13985

F20.0

ICD-10 Finland

Paranoid schizophrenia

11.0

172.3

187

165

F25.1

ICD-10 Finland

Schizoaffective disorder, depressive type

59.9

172.1

ZYC01

NOMESCO Finland

Remote contact by phone

2.5

171.8

1113

4368

SPAT1241

SPAT

Extensive assessment of psychosocial situation

10.1

171.6

198

191

ZXE10

NOMESCO Finland

More than one and less than three hours

1.6

171.5

6619

46419

F25.00

ICD-10 Finland

Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms

11.7

170.4

178

148

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.0

170.0

2106

10775

NAG62

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, 2-3 vertebraea

4.0

169.8

497

1219

M01AB01

ATC

indometacin; systemic, rectal

2.2

169.7

1494

6715

F43.21

ICD-10 Finland

Adaptation disorder with prolonged depression

9.9

169.7

198

194

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.7

169.5

4400

28061

R03BA05

ATC

fluticasone; inhalant

1.7

169.5

3362

19946

TAB20

NOMESCO Finland

Epidural puncture

6.4

169.3

286

436

30040

ICD-8 Finland

Neuroses, Neurotico-depressiva

9.4

168.9

205

212

SPAT1252

SPAT

Overall medication plan or its review

2.3

168.2

1339

5768

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.8

167.5

902

3226

F19.25

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances continuously used

70.0

167.5

ZXY60

NOMESCO Finland

2-person team, nurses

25.3

167.4

120

C08DA01

ATC

verapamil; systemic

2.7

167.3

922

3337

J01DA09

ATC

[U] cefadroxil

1.6

167.3

4957

32655

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

5.0

166.9

365

710

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.6

166.5

4851

31818

309

Kela drug reimbursment

Nalmefene and naltrexone

30.1

165.7

112

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.8

165.6

2969

17096

XKD06

NOMESCO Finland

Physiologic investigation of micturition

3.5

165.3

589

1654

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.5

165.1

1144

4631

R03AC03

ATC

terbutaline; inhalant

1.8

164.9

2619

14536

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.1

164.8

1679

7994

P19

ICPC

Drug abuse

10.7

164.6

182

165

WX408

NOMESCO Finland

General anesthesy, balanced

1.6

164.5

4702

30685

K10.3

ICD-10 Finland

Alveolitis of jaws

2.8

164.3

870

3084

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.4

164.2

1206

5013

SPAT1235

SPAT

Mental health, emotional support

13.3

164.0

158

115

F20

ICD-10 Finland

Schizophrenia

11.8

163.8

170

140

K08.3

ICD-10 Finland

Retained dental root

2.2

163.2

1457

6583

R05

ICPC

Cough

1.6

163.1

4332

27750

R15

ICD-10 Finland

Faecal incontinence

3.3

163.0

645

1936

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.6

162.5

4265

27238

30188

ICD-8 Finland

Personality disorders, Alia definita

15.3

162.4

145

F34.0

ICD-10 Finland

Cyclothymia

35.1

162.3

105

C09CA06

ATC

candesartan; oral

1.6

162.0

4564

29659

IBA03

NOMESCO Finland

Psychotherapy evaluation

17.0

162.0

137

M54

ICD-10 Finland

Dorsalgia

1.9

161.8

2184

11496

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.9

161.5

2378

12880

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

2.7

161.4

910

3332

KMAK, ,

NOMESCO Finland

1.5

161.2

9097

68897

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.7

161.1

946

3536

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.9

160.8

2426

13240

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.8

160.6

2900

16720

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.7

160.6

882

3186

K30

ICD-10 Finland

Functional dyspepsia

1.9

160.5

2124

11103

A07DA03

ATC

loperamide; oral

2.9

160.1

768

2580

L08

ICPC

Shoulder symptom/complaint

1.7

159.4

4055

25674

G54.0

ICD-10 Finland

Brachial plexus disorders

3.6

159.1

538

1459

P58

ICPC

Psychological, Therapeutic counselling/listening

5.7

158.7

302

518

T42.4

ICD-10 Finland

Poisoning: Benzodiazepines

39.9

158.3

E66.9

ICD-10 Finland

Obesity, unspecified

3.1

158.2

679

2140

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.1

158.1

1591

7535

N31.2

ICD-10 Finland

Flaccid neuropathic bladder, not elsewhere classified

6.9

157.9

248

350

M35.7

ICD-10 Finland

Hypermobility syndrome

5.4

157.8

315

565

F45.8

ICD-10 Finland

Other somatoform disorders

2.4

157.7

1164

4847

L13

ICPC

Hip symptom/complaint

1.7

156.8

3501

21413

-1, ,

NOMESCO Finland

1.6

156.7

5552

38028

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.2

156.5

1467

6756

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.1

156.2

1612

7707

N05AX16

ATC

brexpiprazole; oral

55.0

155.8

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.5

155.3

1068

4306

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.6

155.1

4860

32349

TAC99

NOMESCO Finland

Other blockade for chronic pain

7.6

154.8

222

283

R05FA02

ATC

opium derivatives and expectorants; systemic

1.5

154.6

7431

54313

IFA99

NOMESCO Finland

Other psychiatric pharmacotherapy service

21.0

154.5

119

SPAT1053

SPAT

Memory test

1.8

154.0

2512

14034

U02

ICPC

Urinary frequency/urgency

1.8

153.9

2650

15050

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

4.8

153.4

354

721

F41

ICD-10 Finland

Other anxiety disorders

6.3

153.4

261

401

ZXD05

NOMESCO Finland

Urgent procedure

1.6

153.2

5314

36187

Z01.2

ICD-10 Finland

Dental examination

1.5

152.8

7983

59310

XA800

NOMESCO Finland

Neuropsychological investigation

2.9

152.7

749

2546

IAB01, ,

SPAT

34.2

152.0

Z29

ICPC

Social problem NOS

4.4

151.9

388

858

F20.04

ICD-10 Finland

Paranoid schizophrenia with partial recurrence

12.4

151.9

153

120

G47.0

ICD-10 Finland

Disorders of initiating and maintaining sleep [insomnias]

4.2

151.3

417

978

P27

ICPC

Fear of mental disorder

8.4

151.1

201

234

SPAT1227

SPAT

Substance abuse rehabilitation

13.2

151.0

146

107

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.8

150.9

2408

13359

F11.24

ICD-10 Finland

Addiction-induced dependence caused by opiates active addiction

73.9

150.8

N05AB04

ATC

prochlorperazine; systemic, rectal

3.4

150.7

565

1639

R1220

NOMESCO Finland

Psychological examination of need and possibilities to rehabilitation

9.5

150.4

181

185

M01AX05

ATC

glucosamine; oral

1.6

150.1

3849

24372

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

3.4

149.9

558

1611

C10AC01

ATC

colestyramine; oral

3.3

149.6

593

1781

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3031040) Bacteria [#/volume] in Urine by Automated count

13106

98705

1.80

321.59

6.2

4.1

1736.59

1446.63

e6/l

0.25

211

1303

(3026008) Bacteria identified in Urine by Culture

7252

46055

1.81

320.78

4.0

2.9

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

2570

11422

2.34

308.14

2.2

2.3

350.51

378.20

nmol/l

9.07

2338

10564

(3011288) Drugs identified in Urine by Screen method

754

1319

5.68

307.65

5.3

1.9

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

9009

59863

1.81

307.65

3.2

2.7

111.41

136.86

ug/l

14.78

8158

55516

(40760892) CBC W Ordered Manual Differential panel - Blood

10037

69440

1.78

307.65

7.1

6.4

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

11072

74372

1.96

307.65

6.8

6.6

1.22

mmol/l

0.71

9379

63206

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

15299

117888

2.03

307.65

8.3

7.4

79.44

78.62

u/l

1.48

14494

111027

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

15055

116384

1.97

307.65

5.0

3.9

14.69

14.92

pmol/l

24.00

13762

105728

(3009466) Valproate [Moles/volume] in Serum or Plasma

792

1038

7.61

307.65

5.5

4.2

360.67

368.99

umol/l

0.66

689

880

(3013826) Glucose [Moles/volume] in Serum or Plasma

12130

87432

1.84

307.65

5.5

4.4

6.81

6.73

mmol/l

3.37

11452

81864

(3006315) Basophils [#/volume] in Blood

10568

74131

1.78

307.65

6.9

5.8

0.04

e9/l

0.72

9223

64139

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

9996

67183

1.86

307.65

6.2

5.8

1.21

mmol/l

0.12

9078

61125

(3021960) Folate [Moles/volume] in Serum or Plasma

5715

31745

2.02

307.65

1.6

1.5

21.16

20.64

nmol/l

1.35

4875

26895

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

461

251

18.09

307.65

11.8

11.6

848.55

801.60

nmol/l

0.66

446

238

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

5355

30000

1.98

307.65

1.8

1.6

33189123.15

38610786.54

pmol/l

0.26

4378

24812

(3019309) Folate [Moles/volume] in Red Blood Cells

5147

24999

2.32

307.65

1.9

1.7

1199.58

1156.52

nmol/l

2.41

3892

18751

(3001604) Monocytes [#/volume] in Blood

10524

73954

1.78

307.65

6.8

5.8

0.59

0.58

e9/l

1.39

9201

64024

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

7552

45787

1.94

307.65

2.9

2.4

53.99

65.28

u/l

5.36

6891

42401

(3024666) Lithium [Moles/volume] in Serum or Plasma

380

176

21.19

307.65

11.4

14.3

0.62

0.66

mmol/l

1.18

342

161

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

3083

13017

2.51

307.65

2.2

1.5

1.55

1.39

24.71

2636

11490

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

11213

78052

1.86

307.65

5.8

6.2

9.71

11.55

umol/l

55.62

10548

74212

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

7206

43947

1.90

307.65

2.4

2.0

221.75

191.75

u/l

1.46

6752

41078

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

477

269

17.48

307.65

17.0

18.0

3505.66

1396.62

nmol/l

0.53

456

257

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

6142

34435

2.03

307.65

2.5

2.2

3.04

3.03

mg/l

0.04

5245

29511

(3028707) Methadone [Presence] in Urine by Screen method

667

496

13.37

307.65

4.0

2.3

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

9537

63839

1.83

307.65

4.6

4.8

35.40

35.37

g/l

0.17

8803

59193

(3013115) Eosinophils [#/volume] in Blood

10842

76733

1.78

307.65

7.3

5.9

0.19

e9/l

0.37

9603

67210

(3019198) Lymphocytes [#/volume] in Blood

10764

76127

1.78

307.65

7.0

5.8

1.95

1.92

e9/l

0.78

9585

67294

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

9127

61837

1.77

307.65

2.5

2.2

78.72

78.54

nmol/l

0.21

8172

55412

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

9410

58887

2.01

307.65

2.2

1.9

97.32

96.31

pmol/l

1.07

4796

29764

(1001926) Buprenorphine [Presence] in Urine by Screen method

792

1773

4.44

306.33

3.9

1.6

—

(3013707) Erythrocyte sedimentation rate by Westergren method

14515

113470

1.83

305.33

5.0

4.0

13.37

12.64

mm/h

7.45

13442

104981

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

7299

47008

1.78

303.75

3.4

3.1

32.24

34.16

u/l

1.72

6820

44644

(3015377) Calcium [Moles/volume] in Serum or Plasma

7566

49438

1.76

297.97

2.8

3.5

2.35

2.36

mmol/l

1.85

6568

43203

(3013650) Neutrophils [#/volume] in Blood by Automated count

11731

86617

1.73

296.76

11.0

8.9

4.27

4.05

e9/l

18.94

10407

75505

(3037467) Urinalysis macro (dipstick) panel - Urine

13490

103903

1.76

289.80

5.6

4.1

—

(3023368) Bacteria identified in Blood by Culture

6194

38537

1.79

286.15

5.0

4.1

—

(3019069) Monocytes/100 leukocytes in Blood

9843

69966

1.69

279.77

7.5

6.3

8.39

8.62

10.76

9184

65499

(3006504) Eosinophils/100 leukocytes in Blood

9795

69578

1.69

278.73

7.1

6.0

2.76

2.86

4.17

9128

65021

(3022096) Basophils/100 leukocytes in Blood

9530

67378

1.69

274.54

7.1

6.0

0.67

0.69

3.03

8852

62817

(3036180) Methadone [Presence] in Urine

246

158

15.18

273.89

2.1

2.8

—

(3018010) Neutrophils/100 leukocytes in Blood

9894

70791

1.68

271.17

7.0

5.9

57.54

57.28

1.34

9230

66344

(3002030) Lymphocytes/100 leukocytes in Blood

9994

71906

1.67

266.30

7.2

6.1

27.75

27.84

0.37

9335

67468

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

8259

56583

1.69

264.94

4.4

3.3

86.05

55.29

ng/l

0.25

5849

38630

(3018418) pH of Serum or Plasma

6712

43733

1.72

257.65

4.0

4.1

7.40

0.83

1325

8142

(3016879) Cocaine [Presence] in Urine

852

2330

3.63

249.71

4.0

1.5

—

(3022217) INR in Platelet poor plasma by Coagulation assay

9715

70304

1.64

245.46

13.5

14.7

1.20

1.28

inr

9.51

2874

19721

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

3936

22341

1.87

238.86

2.1

1.8

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

16853

141663

1.89

235.04

6.2

4.5

1.82

2.18

mu/l

9.17

15518

129344

(40768797) Stomach Pathology biopsy report

3608

20051

1.89

233.26

1.3

1.2

—

(3000764) Benzodiazepines [Presence] in Urine

876

2605

3.34

225.33

4.0

1.5

—

(3009508) Creatinine [Moles/volume] in Urine

6878

46470

1.65

221.99

3.4

3.1

7.02

7.28

mmol/l

4.87

5696

39120

(3028300) Cannabinoids [Presence] in Urine

875

2643

3.29

219.41

4.0

1.5

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

4855

30021

1.74

218.22

1.3

1.2

1.31

1.83

u/ml

2.67

1244

8115

(3027008) Opiates [Presence] in Urine

872

2638

3.28

218.09

3.9

1.4

—

(3048689) Calprotectin [Mass/mass] in Stool

2946

16026

1.90

200.52

2.2

154.08

137.36

ug/g

0.86

2294

12696

(3035350) Ketones [Presence] in Urine by Test strip

9879

73983

1.56

199.88

4.9

3.5

0.00

estimate

0.30

2195

14103

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

12448

98400

1.57

196.66

4.2

2.8

56.17

47.04

u/l

14.55

11489

91665

(44816559) Phosphatidylethanol [Mass/volume] in Blood

646

1730

3.68

194.88

1.4

1.3

—

(3027944) Amphetamines [Presence] in Urine

834

2629

3.15

194.59

3.7

1.5

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

2053

9949

2.10

193.69

1.7

1.6

—

(3015736) pH of Urine

8169

59053

1.56

190.18

4.5

3.3

5.93

5.84

1.26

376

4467

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

204

177

11.21

190.03

2.4

2.7

137.84

156.87

nmol/l

1.31

172

154

(3009261) Glucose [Presence] in Urine by Test strip

9942

75077

1.54

189.96

4.9

3.5

0.00

estimate

0.03

1995

12948

(3012095) Magnesium [Moles/volume] in Serum or Plasma

3847

23084

1.75

188.58

2.9

3.3

0.82

mmol/l

0.12

3557

21585

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

6310

43110

1.60

186.89

3.1

2.9

1152.41

1477.24

ng/l

9.07

5303

37183

(3021601) Nitrite [Presence] in Urine by Test strip

9825

74182

1.54

186.53

6.4

4.8

0.00

estimate

0.14

2033

13179

(3026782) Osmolality of Urine

4514

28556

1.67

181.25

3.3

2.9

507.50

539.08

mosm/kgh2o

16.35

3922

24549

(3022948) Iron [Moles/volume] in Serum or Plasma

3728

22460

1.74

179.06

2.4

2.5

12.34

13.00

umol/l

6.14

3427

20992

(3002582) Erythrocytes [#/volume] in Urine

6355

43871

1.58

178.08

3.7

3.1

71.56

97.96

e6/l

0.59

4984

33351

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

135

21.46

176.95

1.9

2.5

15.78

19.13

umol/l

1.37

135

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

245

300

7.95

176.70

2.1

1.7

112.03

111.58

umol/l

0.01

125

149

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

4932

32155

1.63

174.95

1.8

1.7

1.08

1.25

mg/l

3.99

3785

24920

(3018095) Leukocytes [#/volume] in Urine

7237

51660

1.55

173.73

4.3

3.5

106.25

102.40

e6/l

0.11

5304

36153

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2745

15238

1.85

173.35

2.0

1.7

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2748

15276

1.85

172.71

2.0

1.7

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

4208

26524

1.67

169.74

2.7

3.2

2.45

2.46

mmol/l

2.37

3623

23193

(3020682) Albumin/Creatinine [Ratio] in Urine

6746

47615

1.55

169.30

3.8

8.06

8.35

mg/mmol

0.16

4219

29328

(3007164) IgA [Mass/volume] in Serum or Plasma

4174

26279

1.67

169.03

1.5

2.41

2.45

g/l

0.59

2401

16030

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

161

116

13.47

168.14

2.1

3.6

—

(3000850) Epithelial cells [#/volume] in Urine

4605

29961

1.62

162.84

3.0

2.5

6.77

5.55

e6/l

3.96

4171

26821

(3030467) Casts [#/volume] in Urine by Automated count

5837

40158

1.56

162.80

3.6

3.0

0.40

0.43

e6/l

0.57

4579

30344

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1707

8229

2.09

162.00

3.9

3.5

5.28

5.12

kpa

11.52

1630

7750

(3009343) pH of Capillary blood

1684

8107

2.09

160.33

3.9

3.4

7.41

7.42

0.88

234

999

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1641

7827

2.11

160.11

3.8

3.4

2.01

1.79

mmol/l

1.53

1277

5697

(3004789) Transferrin [Mass/volume] in Serum or Plasma

3427

20739

1.71

159.95

2.4

2.5

2.40

2.32

g/l

11.05

3118

19271

(3012516) Albumin [Mass/volume] in Urine

6392

45131

1.53

157.39

3.3

3.2

352.76

420.33

mg/l

0.56

4033

27889

(3003458) Phosphate [Moles/volume] in Serum or Plasma

3117

18450

1.74

157.30

4.8

5.9

1.04

mmol/l

0.08

2882

17177

(3007853) Bacteria identified in Skin by Aerobe culture

2863

16628

1.77

154.12

1.9

1.7

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

978

3840

2.53

150.43

1.5

1.4

279.82

272.87

ug/g

0.31

549

2304

(3042936) Bacteria identified in Isolate by Culture

3331

20377

1.69

148.17

2.3

1.9

—

(36304419) Bacteria [Presence] in Urine

5617

38969

1.54

147.95

3.6

2.9

—

(3021589) Normoblasts [#/volume] in Blood

8746

66554

1.47

146.20

11.5

9.2

0.00

e9/l

0.44

7272

54724

(3042517) Benzodiazepines panel - Urine

51.40

143.57

2.2

1.3

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

2769

16297

1.74

141.26

6.8

6.9

5.24

5.06

kpa

16.78

2644

15524

(3027801) Oxygen [Partial pressure] in Arterial blood

2767

16290

1.74

140.99

6.8

6.9

11.41

12.74

kpa

40.46

2633

15507

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

3185

19522

1.68

139.81

2.5

2.6

20.64

22.62

13.17

2676

16694

(3002032) Base excess in Venous blood by calculation

2286

12789

1.81

138.58

4.2

3.8

2.18

1.91

mmol/l

2.83

1982

10896

(3003396) Base excess in Arterial blood by calculation

2755

16280

1.73

138.30

6.9

1.49

1.00

mmol/l

8.24

2246

12906

(3012544) pH of Venous blood

2351

13314

1.79

136.72

4.1

3.8

7.38

0.26

(3021447) Carbon dioxide [Partial pressure] in Venous blood

2283

12820

1.81

136.57

4.2

3.8

5.92

5.80

kpa

6.41

2210

12476

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

3979

26006

1.59

134.31

1.3

32.96

38.64

iu/ml

1.12

1159

8886

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

16493

143677

1.58

130.24

7.3

5.5

40.76

39.75

mmol/mol

33.18

15187

132643

(3000494) Fungus identified in Specimen by Culture

2798

16904

1.69

128.74

1.5

1.4

—

(3037522) Nuclear Ab [Titer] in Serum

3181

19912

1.64

127.49

1.4

1.3

476.35

584.22

titre

2.69

647

4386

(3016502) Oxygen saturation in Arterial blood

2480

14545

1.73

127.09

7.0

7.3

94.97

95.89

10.72

2403

13965

(3024354) Oxygen [Partial pressure] in Venous blood

1913

10435

1.85

125.20

3.8

3.0

4.69

4.54

kpa

1.87

1837

10126

(3023183) Ammonium ion [Moles/volume] in Plasma

674

2459

2.70

120.04

2.8

2.6

32.64

33.73

umol/l

0.65

613

2209

(3014111) Lactate [Moles/volume] in Serum or Plasma

2121

12120

1.77

118.58

6.6

6.7

1.40

1.33

mmol/l

2.22

2069

11806

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

3713

24514

1.56

117.99

1.3

1.2

11.50

14.42

u/ml

1.50

1339

9691

(3020191) Ethanol [Moles/volume] in Serum or Plasma

309

700

4.30

117.32

1.8

1.2

1.40

1.19

promille

1.43

238

552

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

17464

155180

1.63

115.80

20.1

13.1

22.57

23.83

mg/l

5.63

14854

121290

(3029937) Albumin [Presence] in Urine by Test strip

5480

39399

1.47

115.47

5.4

3.9

0.00

estimate

5.02

2009

12705

(3027945) Reticulocytes/100 erythrocytes in Blood

2621

16005

1.66

114.71

2.3

2.5

1.83

1.77

2.57

2272

14221

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

2224

13045

1.72

113.04

2.8

2.4

33.10

46.90

u/l

1.66

1854

11193

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

7497

57280

1.42

112.90

5.3

3.7

—

(3019060) Gas panel - Arterial blood

1696

9235

1.84

111.02

4.9

4.7

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

17957

161157

1.67

108.45

22.6

15.0

139.44

139.76

mmol/l

48.88

17587

156936

(40758558) Short blood count panel - Blood

5247

37813

1.46

107.73

7.7

6.8

—

(3019150) Specific gravity of Urine by Refractometry

4540

31936

1.48

105.18

5.4

3.9

1.03

1.02

kg/l

0.50

665

5052

(3023103) Potassium [Moles/volume] in Serum or Plasma

17982

161657

1.66

105.05

22.7

15.1

3.97

mmol/l

0.64

17600

157112

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1501

7999

1.87

104.99

1.6

1.4

—

(3022145) Colonoscopy Study observation

2661

16695

1.62

103.73

1.3

—

(3022313) Gas panel - Capillary blood

1185

5857

2.01

103.58

4.1

3.6

—

(3013512) EKG study

6027

44898

1.42

102.10

4.6

3.8

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

4862

34937

1.45

99.99

4.6

3.5

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

2024

12006

1.69

97.88

3.7

3.8

1.23

mmol/l

0.90

1766

10574

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

977

4601

2.10

97.31

2.1

2.3

433.76

591.37

ug/l

1.02

906

4305

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

2208

13464

1.65

95.96

2.2

0.21

g/l

0.48

2042

12651

(3023520) Reticulocytes [#/volume] in Blood

2015

12003

1.69

95.81

2.2

2.7

71.12

68.95

e9/l

1.96

1537

9151

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1469

8043

1.82

93.87

1.9

1.6

—

(3017181) Myelocytes/100 leukocytes in Blood

2074

12574

1.66

91.97

4.4

4.2

0.89

0.96

0.61

717

4332

(4200892) Spirometry reversibility

1785

10418

1.71

91.33

1.5

1.4

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1031

5073

2.01

91.03

4.3

3.8

24.98

24.88

mmol/l

0.54

972

4641

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1563

8806

1.77

90.60

2.8

3.5

4.31

4.48

pmol/l

9.79

1342

7904

(3002179) Metamyelocytes/100 leukocytes in Blood

1912

11395

1.68

90.47

4.2

4.0

0.61

0.73

1.31

625

3738

(3021387) Prolactin [Units/volume] in Serum or Plasma

716

3068

2.29

90.15

1.6

1.7

364.46

298.40

mu/l

2.31

626

2824

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

8934

71994

1.35

90.12

2.8

2.5

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

2193

13550

1.63

90.08

7.5

7.7

120.90

120.45

g/l

0.49

2140

13163

(3044640) Blood type and Crossmatch panel - Blood

6293

48058

1.38

89.21

2.6

2.3

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

4043

28578

1.45

89.09

4.3

3.6

213.54

500.35

ng/l

6.33

3043

22445

(21494755) Public health laboratory ask at order entry panel

742

14591

0.47

88.91

1.4

—

(3021440) Promyelocytes/100 leukocytes in Blood

1973

11961

1.65

87.25

4.4

4.2

0.11

0.12

0.06

621

3738

(3044889) 12 lead EKG panel

12754

108797

1.35

86.31

4.4

3.6

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

2570

16641

1.56

86.30

2.6

2.7

6.83

8.91

umol/l

6.88

2116

14626

(3033658) Prothrombin time (PT) actual/Normal

5117

37938

1.40

85.95

4.5

3.7

93.49

90.37

15.75

4957

37045

(3025941) Bacteria identified in Stool by Culture

1383

7654

1.80

85.00

1.3

1.2

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

3567

24889

1.46

83.39

3.1

2.7

1.98

1.17

e6/l

0.54

2110

14235

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1086

5628

1.91

82.26

1.3

1.2

0.55

0.98

u/ml

1.14

115

519

(3000991) Gas panel - Venous blood

1909

11653

1.64

81.88

7.8

8.1

—

(3025159) Blasts/100 leukocytes in Blood

1859

11346

1.64

79.68

4.5

4.2

0.06

0.49

4.98

509

3183

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1545

8989

1.71

79.51

7.2

6.8

25.16

24.51

mmol/l

9.33

1481

8527

(3015235) Bicarbonate [Moles/volume] in Capillary blood

729

3321

2.16

78.95

3.2

2.9

25.43

24.67

mmol/l

4.61

714

3250

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

810

3871

2.06

77.34

1.3

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

2864

19399

1.49

77.18

1.8

1.7

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

1494

8697

1.71

76.63

3.9

3.2

127.63

127.92

g/l

0.20

1444

8509

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1182

6474

1.81

74.96

4.7

3.8

49.81

47.20

3.05

1167

6409

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1846

11421

1.61

74.64

3.3

3.9

86.81

91.60

ng/l

1.28

1557

9810

(3017143) Hepatitis C virus Ab [Presence] in Serum

2215

14316

1.55

74.20

1.6

—

(3003181) Sodium [Moles/volume] in Urine

547

2271

2.36

74.03

1.5

1.3

58.05

63.34

mmol/l

2.35

421

1845

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1188

6547

1.80

73.79

3.5

2.7

1.42

1.19

9.73

1177

6509

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1135

6172

1.82

73.69

4.2

4.3

24.38

24.11

mmol/l

1.98

1104

6038

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

2277

14841

1.54

73.37

4.3

3.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1431

8342

1.70

72.90

1.9

1.7

—

(36660697) Celiac disease serology panel - Serum

1749

10748

1.62

72.61

1.2

1.1

—

(3019225) pH of Specimen

2296

15042

1.53

72.17

4.3

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

3199

22443

1.44

71.40

1.9

2.1

29.62

29.77

0.63

3088

21786

(3027273) Bicarbonate [Moles/volume] in Venous blood

1244

7044

1.75

70.31

4.0

3.3

25.58

25.25

mmol/l

2.54

1211

6846

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1157

6433

1.78

69.65

3.4

2.7

0.66

0.21

1148

6404

(3026493) Urate [Moles/volume] in Serum or Plasma

5269

40351

1.35

69.40

2.5

2.6

4385.37

4807.48

umol/l

0.31

4468

35462

(3028626) Oxygen [Partial pressure] in Capillary blood

621

2804

2.17

68.73

2.9

2.7

7.98

8.12

kpa

1.38

608

2739

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1560

9474

1.64

67.73

2.0

1.7

—

(3020779) Urea [Moles/volume] in Serum or Plasma

1970

12646

1.56

67.67

5.8

7.4

9.46

10.23

mmol/l

4.93

1846

12020

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

3249

23062

1.43

67.62

3.3

2.8

3.32

3.04

e6/l

0.66

1802

12534

(3005719) IgG [Mass/volume] in Serum or Plasma

1725

10799

1.59

66.01

2.6

2.9

10.21

10.64

g/l

3.67

1550

9968

(3008295) Osmolality of Serum or Plasma

339

1184

2.79

65.64

1.4

277.26

278.48

mosm/kgh2o

0.37

263

940

(3041096) Erythrocytes [Presence] in Urine by Automated

5168

39742

1.34

65.45

4.6

3.2

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

14.03

65.28

8.0

10.9

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

808

14025

0.54

64.75

1.7

1.8

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

630

2946

2.09

63.69

1.3

519.77

573.28

mg/l

0.67

592

2830

(3009214) Lutropin [Units/volume] in Serum or Plasma

586

2666

2.15

63.62

1.4

1.3

11.43

12.65

u/l

1.04

463

2213

(3004588) Protein electrophoresis panel - Serum or Plasma

1597

9932

1.60

62.71

2.2

2.5

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

16814

152156

1.39

62.19

5.7

4.4

6.13

5.91

mmol/l

71.98

15296

139021

(3003327) Ova and parasites identified in Stool by Light microscopy

833

4344

1.88

61.65

1.7

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

570

2612

2.13

60.75

1.3

1.2

3.91

3.76

mmol/l

2.50

529

2463

(3021901) Oxygen saturation in Capillary blood

537

2407

2.18

60.53

2.9

2.7

—

(3018405) Lactate [Moles/volume] in Arterial blood

912

4944

1.81

59.61

4.0

3.9

1.39

1.37

mmol/l

0.27

903

4856

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

294

1010

2.83

58.76

1.7

1.8

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1902

12491

1.52

58.38

2.5

2.2

5.38

7.38

ug/l

4.10

1553

10978

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1237

7371

1.66

57.61

8.2

9.0

24.60

24.30

mmol/l

2.48

1184

7129

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

4731

36469

1.33

57.53

2.6

2.3

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

253

814

3.02

56.91

1.5

2.1

17.37

16.52

nmol/l

0.88

238

773

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1444

8968

1.59

56.84

8.1

8.6

1.52

1.33

7.55

1436

8903

(3014765) Yersinia sp identified in Stool by Organism specific culture

743

3833

1.90

56.81

1.2

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

2683

18940

1.42

56.61

8.9

6.6

—

(3026389) Candida sp identified in Specimen by Organism specific culture

464

2015

2.25

56.54

1.5

1.3

—

(40761535) Cells panel - Urine sediment

1853

12184

1.51

56.45

4.0

3.4

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

735

3793

1.90

56.14

1.2

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

553

2582

2.09

56.12

1.4

1517.72

2186.26

e6/l

0.31

450

2106

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1438

8957

1.59

55.87

8.2

8.7

0.68

0.04

1432

8903

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

625

3058

2.00

55.82

1.4

—

(42529406) Shigella sp [Presence] in Stool by Culture

741

3844

1.89

55.69

1.2

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

551

2580

2.09

55.50

1.4

14.27

38.56

e6/l

2.76

429

1995

(3028026) IgM [Mass/volume] in Serum or Plasma

1364

8424

1.60

54.91

1.7

1.9

1.23

1.34

g/l

1.41

1231

7686

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1001

5726

1.72

54.28

2.1

1.9

2.41

2.52

ug/l

0.08

865

5076

(3020630) Protein [Mass/volume] in Serum or Plasma

1835

12191

1.50

53.02

2.3

2.7

66.25

66.45

g/l

0.55

1645

11071

(3020891) Body temperature

979

5612

1.72

52.66

5.4

4.5

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

1033

6020

1.69

52.28

5.4

4.9

0.86

0.89

1.88

980

5632

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1047

6124

1.68

52.26

5.3

4.8

1.74

1.61

2.21

991

5732

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1303

8067

1.59

51.83

2.5

2.4

—

(1616796) Gas panel - Central venous blood

587

2921

1.96

49.95

4.1

3.4

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

575

2848

1.97

49.59

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

575

2848

1.97

49.59

1.4

1.3

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

618

3158

1.91

48.62

2.3

2.1

129.84

128.49

g/l

0.62

457

2237

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

7.58

48.19

1.2

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

208

663

3.04

47.63

1.8

1.2

—

(3044290) Cell count panel - Cerebral spinal fluid

515

2489

2.02

47.62

1.3

—

(3010421) pH of Blood

669

3544

1.85

47.06

4.9

3.6

7.42

2.22

587

3242

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

419

1890

2.16

46.53

2.2

1.8

194.09

198.51

pmol/l

0.37

390

1795

(3006653) Thiamine [Moles/volume] in Blood

178

526

3.28

46.27

1.2

145.91

134.45

nmol/l

1.72

178

526

(40767503) Oxygen content in Capillary blood by calculation

568

2872

1.93

46.12

2.9

2.4

16.24

16.22

0.04

315

1424

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

543

2706

1.96

46.02

1.8

1.5

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1095

6689

1.61

45.95

1.1

1.0

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

2362

16884

1.39

45.59

3.1

4.5

236.08

248.15

u/l

3.33

2182

15996

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

16268

148073

1.30

45.31

17.3

12.5

79.67

79.27

ml/min/173m2

1.58

13744

122005

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

+∞

45.20

1.4

0.0

558.35

—

nmol/l

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1301

8316

1.54

44.84

6.7

6.8

25.19

24.72

mmol/l

4.40

1283

8251

(40761536) Microorganisms panel - Urine sediment

1754

11962

1.45

43.98

5.2

3.8

—

(3008402) Methanol [Moles/volume] in Serum or Plasma

7.75

43.47

1.1

—

mmol/l

—

(3005322) IgE [Units/volume] in Serum or Plasma

1351

8770

1.52

43.31

1.3

221.10

223.60

u/ml

0.02

1243

8094

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

986

5975

1.62

42.72

2.1

1.9

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

159

462

3.33

42.50

1.7

1.3

1768830.33

2428427.17

iu/ml

0.17

(3023511) Choriogonadotropin [Units/volume] in Urine

315

1312

2.33

42.43

1.6

1.2

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

524

9157

0.54

42.26

1.5

1.4

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

2395

17430

1.37

41.11

1.6

—

(3028271) Lactate [Moles/volume] in Capillary blood

439

2119

2.02

40.77

2.1

1.8

1.69

1.72

mmol/l

0.22

430

2065

(3012501) Base excess in Blood by calculation

577

3063

1.84

40.33

4.9

3.6

2.66

2.53

mmol/l

0.49

411

2095

(3013290) Carbon dioxide [Partial pressure] in Blood

577

3064

1.84

40.29

4.9

3.6

5.09

4.96

kpa

3.42

560

3002

(3027315) Oxygen [Partial pressure] in Blood

580

3086

1.84

40.24

4.9

3.6

8.33

8.63

kpa

3.95

563

3024

(3023419) Bacteria identified in Sputum by Culture

435

2103

2.02

40.23

2.8

2.5

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

767

4456

1.68

39.17

1.6

1.22

1.17

g/l

4.72

723

4234

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

747

4314

1.69

39.01

1.6

1.7

0.24

0.23

g/l

1.45

704

4072

(3005988) Vibrio sp identified in Specimen by Organism specific culture

385

1801

2.08

38.96

1.4

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1786

12497

1.41

38.68

2.9

2.8

157.49

218.14

ng/l

7.80

1606

11434

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

907

5520

1.61

38.57

1.1

1.15

9.20

u/ml

0.90

(3025468) Yersinia sp identified in Specimen by Organism specific culture

383

1798

2.07

38.40

1.4

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

1040

6545

1.56

38.33

1.5

1.7

1.66

1.55

g/l

3.13

881

5554

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

383

1800

2.07

38.28

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

384

1807

2.07

38.25

1.4

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

895

5442

1.61

38.20

2.0

1.8

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

391

1861

2.04

37.77

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

383

1819

2.05

37.23

1.4

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

522

2756

1.85

37.14

2.0

1.6

41.30

42.84

nmol/l

0.74

510

2664

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

371

1747

2.07

36.91

1.4

1.3

31.45

35.98

u/l

1.56

285

1436

(3023323) Follitropin [Units/volume] in Serum or Plasma

916

5658

1.59

36.59

1.4

1.3

29.84

35.51

iu/l

5.57

774

4998

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

831

5021

1.62

36.39

2.8

2.6

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1394

9433

1.46

36.18

1.2

104.02

157.68

iu/ml

5.87

496

3707

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1214

7995

1.49

36.17

2.6

2.0

12.34

nmol/l

0.00

1040

7197

(3009445) Proteinase 3 Ab [Units/volume] in Serum

1007

6399

1.54

35.50

1.3

1.6

18.41

16.63

u/ml

—

200

(3040151) Glucose [Moles/volume] in Capillary blood

331

1523

2.11

35.03

5.3

6.3

7.78

7.53

mmol/l

0.22

265

1241

(3017732) Neutrophils [#/volume] in Blood

1508

10433

1.42

34.67

3.8

2.8

5.38

4.84

e9/l

0.67

1159

8377

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

748

4471

1.64

34.21

1.7

—

(3000475) Leukocytes [#/volume] in Synovial fluid

642

3692

1.70

34.07

1.7

1.6

12373.48

13086.55

e6/l

0.17

480

2715

(3035637) Corticotropin [Mass/volume] in Plasma

343

1620

2.06

33.88

1.5

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1436

9914

1.43

33.37

2.4

20.31

24.78

au/ml

0.97

796

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1314

8971

1.44

32.44

1.3

46.34

56.68

au/ml

0.93

517

(3022806) Fractional oxyhemoglobin in Capillary blood

355

1729

2.00

32.24

2.0

1.7

88.59

89.82

3.11

349

1704

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

4962

40841

1.23

31.54

1.7

1.6

1.55

1.32

mmol/l

33.43

4140

34360

(3002385) Erythrocyte distribution width [Ratio]

14728

134075

1.22

31.50

23.1

15.6

15.35

15.10

2.70

14504

131614

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1170

7858

1.46

31.49

9.5

9.2

—

(1761868) Lipid panel - Serum or Plasma

5082

56625

0.82

31.16

3.3

2.8

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

2988

23269

1.28

30.95

1.5

1.4

—

(3007566) Smooth muscle Ab [Titer] in Serum

660

3923

1.64

30.87

1.2

114.48

154.18

titre

0.69

361

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

679

4077

1.63

30.50

1.3

27.20

42.90

u/ml

0.93

247

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

579

3338

1.69

30.46

1.6

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

674

4054

1.62

30.07

1.5

1.4

—

(3052851) Hemolysis interference index of Serum or Plasma

720

4403

1.60

30.00

3.2

3.1

—

(3034770) Mitochondria Ab [Titer] in Serum

657

3934

1.63

29.85

1.2

640.00

1113.15

titre

1.67

162

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

963

6290

1.50

29.80

1.9

2.0

38.86

39.78

u/l

0.75

853

5547

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

2096

15664

1.32

29.52

1.6

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

694

4229

1.60

29.35

1.9

1.6

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

403

2121

1.85

29.05

1.1

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

553

3204

1.68

28.58

1.6

1.7

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

190

757

2.43

28.44

1.4

1.2

218.01

387.53

u/l

1.69

169

706

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

17944

167397

1.30

28.12

13.4

9.9

26.59

25.64

u/l

5.81

17348

161318

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

185

733

2.45

28.04

1.0

263.02

397.53

ng/l

2.04

128

542

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

186

739

2.44

28.02

1.0

35.62

44.18

ng/l

2.48

124

538

(40761511) CBC panel - Blood by Automated count

17486

162633

1.27

27.80

19.0

12.3

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

354

1821

1.89

27.43

7.2

6.0

11.45

11.75

mg/l

0.70

324

1654

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

517

2975

1.69

27.42

1.2

41.91

47.04

u/ml

0.29

315

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

184

736

2.42

27.33

1.0

870.39

723.54

ng/l

3.02

122

525

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

394

2102

1.82

27.21

1.4

—

(3047181) Lactate [Moles/volume] in Blood

732

4600

1.55

27.12

6.6

5.7

1.32

1.29

mmol/l

0.44

647

4059

(3045414) Leukocytes [Presence] in Urine

1014

6817

1.46

27.11

2.0

1.8

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

620

3757

1.61

26.86

1.3

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

597

3588

1.62

26.75

2.1

2.3

99.43

101.36

ug/min

0.03

325

2128

(3000330) Specific gravity of Urine by Test strip

1154

7965

1.42

26.74

4.5

3.4

—

(3017569) Oxygen content in Arterial blood

157

589

2.58

26.71

2.1

2.0

—

(3024928) Oxygen saturation in Venous blood

488

2800

1.70

26.18

3.5

3.2

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

419

2304

1.77

26.17

1.5

0.62

0.79

g/l

3.57

312

1749

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

441

2463

1.74

26.09

1.4

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

789

5089

1.51

25.93

1.8

1.7

—

(3020961) Endomysium IgA Ab [Titer] in Serum

943

6308

1.46

25.87

1.1

185.36

242.92

titre

0.25

173

(3016038) Potassium [Moles/volume] in Urine

197

833

2.29

25.83

1.3

1.1

27.80

35.40

mmol/l

5.58

148

731

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

385

2075

1.80

25.74

1.3

0.15

0.24

nmol/l

2.40

121

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

621

3805

1.59

25.69

1.3

4.62

6.77

u/ml

1.21

101

617

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

525

3090

1.65

25.58

1.2

8.91

10.99

u/ml

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

612

3752

1.59

25.26

1.3

9.75

6.46

u/ml

0.40

409

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

186

775

2.32

25.25

1.4

4.92

5.87

u/l

2.38

157

654

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

445

2519

1.72

25.11

1.2

1.3

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

382

2074

1.79

24.93

1.3

1.74

1.78

nmol/l

0.01

371

1996

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

648

4040

1.56

24.88

1.9

2.1

11.69

11.08

mg/l

0.71

601

3738

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

249

1176

2.05

24.74

1.3

1.63

1.38

nmol/l

2.49

226

1059

(3044941) Cell count panel - Synovial fluid

418

2335

1.74

24.73

1.6

1.4

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

479

2789

1.67

24.35

1.8

0.89

0.81

nmol/l

1.83

402

2347

(3024139) IgG subclass 3 [Mass/volume] in Serum

287

1434

1.94

24.33

1.4

0.35

0.42

g/l

3.35

201

1002

(3022621) pH of Urine by Test strip

1400

10137

1.36

24.26

3.6

2.9

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

287

1436

1.94

24.24

1.4

6.11

6.95

g/l

4.37

199

1003

(3028192) IgG subclass 2 [Mass/volume] in Serum

287

1436

1.94

24.24

1.4

2.73

2.98

g/l

1.81

201

1003

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

391

2156

1.76

24.22

1.1

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

426

2407

1.72

24.21

1.6

1.7

—

(3016018) Differential panel - Cerebral spinal fluid

270

1325

1.98

24.12

1.5

1.4

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

212

952

2.16

24.05

1.3

1.2

2.05

2.15

mmol/l

0.66

196

886

(3013005) Retinol [Moles/volume] in Serum or Plasma

126

447

2.73

24.00

1.8

1.6

2.24

1.96

umol/l

2.67

114

420

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

344

1834

1.82

23.87

1.4

—

(4062490) Immunoglobulin typing, IgG

285

1431

1.93

23.83

1.5

1.4

—

(1002224) Polysomnography panel

786

5164

1.49

23.63

1.1

—

(3019977) pH of Arterial blood

171

708

2.34

23.59

3.0

2.2

7.41

7.42

0.92

242

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

765

5006

1.49

23.46

1.6

121.58

296.19

titre

3.99

227

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

625

3918

1.55

23.44

1.7

1.6

—

(3021788) Differential panel - Synovial fluid

473

2774

1.66

23.40

1.6

1.5

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

128

464

2.67

23.39

1.3

1.2

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

356

1931

1.79

23.34

1.6

54.86

57.04

0.42

220

1240

(3044242) Glucose [Moles/volume] in Arterial blood

153

608

2.44

23.14

2.2

1.8

—

(3016244) Insulin [Units/volume] in Serum or Plasma

153

608

2.44

23.14

3.0

3.2

24.17

26.25

mu/l

0.30

144

575

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

10244

91513

1.16

22.89

3.0

2.6

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

243

1173

2.01

22.78

1.7

1.5

—

(3011985) Renin [Units/volume] in Plasma

355

1944

1.77

22.55

1.4

1.5

60.24

55.76

mu/l

0.20

315

1736

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

840

5646

1.45

22.48

2.1

2.3

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

790

5249

1.47

22.45

2.1

2.3

9.71

10.30

g/l

3.43

698

4635

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

194

867

2.17

22.32

1.2

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

840

5654

1.45

22.31

2.1

2.3

7.51

7.41

g/l

1.00

752

5074

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

343

1869

1.78

22.17

2.2

2.0

23.76

26.55

mg/l

0.44

105

482

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

669

4312

1.51

22.09

2.1

2.3

38.09

37.67

g/l

1.05

582

3720

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

122

445

2.65

22.06

2.6

3.2

29.51

28.78

umol/l

0.24

348

(3013139) Helicobacter pylori Ag [Presence] in Stool

1375

10076

1.34

21.96

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

192

861

2.16

21.91

1.2

1.3

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

835

5637

1.45

21.84

2.1

2.3

3.65

3.70

g/l

0.48

748

5064

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

345

1896

1.77

21.67

1.3

—

(3008037) Lactate [Moles/volume] in Venous blood

553

3436

1.57

21.60

4.0

3.0

1.55

1.56

mmol/l

0.14

543

3369

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

332

1808

1.78

21.52

1.3

—

nmol/l

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

787

5271

1.46

21.47

2.2

2.4

2.95

2.94

g/l

0.07

700

4694

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

123

459

2.59

21.26

1.5

14.68

16.21

pmol/l

1.85

393

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

511

3129

1.59

21.26

1.2

4.66

6.58

u/ml

0.27

261

(3042631) Mycobacterium sp identified in Specimen

354

1974

1.74

21.15

2.9

2.6

—

(3014271) Vancomycin [Susceptibility]

158

664

2.30

21.12

3.2

2.8

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

332

1821

1.77

21.01

1.3

302.60

366.98

pmol/l

0.55

287

1591

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1298

9493

1.34

21.00

1.4

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

714

4713

1.48

20.99

2.3

2.5

0.75

0.97

g/l

1.00

620

4015

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1096

7811

1.37

20.97

3.0

2.6

0.29

0.28

e6/l

0.08

1072

7603

(3023410) Appearance of Cerebral spinal fluid

238

1181

1.95

20.67

1.6

1.5

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

135

535

2.44

20.60

2.6

2.3

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

224

1092

1.99

20.48

1.5

1.4

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

197

918

2.08

20.39

1.3

1.4

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

638

4144

1.50

20.33

2.3

2.4

0.03

g/l

0.12

585

3781

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

596

3824

1.52

20.14

2.3

2.4

0.00

g/l

0.04

543

3476

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

631

4098

1.50

20.12

1.3

1.5

28.71

14.05

iu/ml

0.90

101

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

582

3718

1.52

20.07

1.1

2.06

9.16

u/ml

7.31

455

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

477

2915

1.59

20.04

2.3

2.1

3633.37

4286.07

u/l

0.24

158

1213

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

589

3777

1.52

19.96

2.3

2.4

0.00

g/l

-0.00

541

3469

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

194

907

2.07

19.92

1.3

1.4

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

167

739

2.19

19.76

1.1

1.25

8.93

nmol/l

2.64

161

(3004716) Salmonella sp identified in Stool by Organism specific culture

952

6697

1.39

19.73

1.3

1.4

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

218

1069

1.98

19.62

1.4

1.6

22.61

25.08

u/ml

0.32

212

(3017509) Phencyclidine [Presence] in Urine

5.22

19.60

2.5

1.1

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

348

1976

1.71

19.52

1.5

1.4

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

273

1450

1.83

19.28

1.5

1.8

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

777

5300

1.43

19.23

1.6

1.7

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

267

1410

1.84

19.21

1.6

1.5

31.84

30.50

0.21

148

876

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

141

591

2.31

19.02

1.7

1.6

2.44

7.70

nmol/l

0.74

108

505

(40768804) Tissue Pathology biopsy report

7398

65124

1.15

18.86

2.1

—

(3038515) Glucose [Moles/volume] in Venous blood

520

3287

1.54

18.86

4.1

3.1

7.55

7.52

mmol/l

0.10

510

3229

(3034860) Kappa light chains.free [Mass/volume] in Serum

708

4771

1.45

18.73

2.7

3.5

121.77

73.11

mg/l

0.26

576

3901

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

706

4762

1.44

18.58

2.7

3.5

44.66

48.84

mg/l

0.19

574

3895

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

420

2538

1.61

18.53

1.2

—

(3037121) Protein [Mass/volume] in Urine

745

5079

1.43

18.50

2.8

3.2

0.30

0.31

g/l

0.11

237

2123

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

190

915

2.01

18.05

1.3

1.1

—

(3039000) Anion gap in Blood

513

3265

1.53

18.04

7.6

6.6

10.81

11.16

mmol/l

1.57

467

2918

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

265

2.95

18.03

1.3

1.2

—

(3018572) Chloride [Moles/volume] in Blood

513

3266

1.53

18.02

7.6

6.6

104.75

105.20

mmol/l

1.11

467

2919

(3000492) Spirometry study

1810

14112

1.26

17.94

1.6

1.5

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

685

4636

1.44

17.72

2.7

3.4

1.44

5.61

ratio

1.91

355

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

235

1229

1.85

17.49

1.1

—

67.94

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

460

2884

1.55

17.35

1.2

165.71

154.84

titre

—

(3008898) HLA-B27 [Presence]

650

4378

1.44

17.26

1.1

—

(40768443) Skin Pathology biopsy report

958

6897

1.36

17.19

1.2

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

324

1870

1.68

17.17

1.6

1.5

—

(1761482) Bacteria [#/volume] in Urine by Culture

629

4218

1.45

17.10

5.9

4.0

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

2412

19523

1.22

16.82

5.1

4.5

31.47

32.89

7.59

1636

13249

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

382

2322

1.60

16.50

1.4

1.5

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

325

1898

1.66

16.49

1.7

1.6

—

(40757494) Bilirubin.total [Moles/volume] in Blood

159

743

2.07

16.44

2.0

2.2

15.15

30.62

umol/l

1.01

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

132

576

2.22

16.26

1.2

1.3

63.36

60.70

0.10

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

183

904

1.96

16.23

1.2

1.3

20.00

57.43

titre

—

(3049717) Cytology report of Urine Cyto stain

769

5400

1.39

16.14

2.4

2.7

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

207

1068

1.88

16.12

1.7

1.5

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

152

704

2.09

16.11

1.4

1.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

152

704

2.09

16.11

1.4

1.5

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

187

934

1.94

16.06

1.3

618.18

416.29

titre

0.17

(3010838) Calcium [Moles/time] in 24 hour Urine

456

2909

1.52

15.92

1.8

1.9

4.77

5.13

mmol/24h

1.53

398

2552

(3006270) Folate [Moles/volume] in Blood

222

1176

1.83

15.91

1.2

360.83

350.21

nmol/l

0.29

181

982

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

295

1701

1.68

15.73

1.1

1.2

53.32

62.47

u/l

3.08

266

1519

(3004809) Band form neutrophils/100 leukocytes in Blood

398

2471

1.56

15.72

3.0

3.5

1.56

1.62

0.12

343

2204

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

249

1377

1.75

15.46

3.7

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

435

2768

1.53

15.38

2.7

3.1

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

375

2311

1.57

15.31

1.5

1.7

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

375

2311

1.57

15.31

1.5

1.7

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

245

1360

1.74

15.03

1.5

1.8

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

228

1240

1.78

15.01

1.4

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

228

1240

1.78

15.01

1.4

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

228

1240

1.78

15.01

1.4

1.7

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

261

2.78

15.00

1.2

1.6

74.85

72.47

1.13

249

(3004616) Nuclear Ab [Presence] in Serum

309

1832

1.64

14.83

1.3

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

153

734

2.02

14.79

1.5

4.77

3.73

0.19

174

(4146454) Self-monitoring of blood glucose

273

1571

1.68

14.71

2.4

2.7

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

5.17

14.60

1.1

1.3

43.48

37.91

mg/l

—

(40760888) Immunoglobulin light chains.free panel - Serum

539

3623

1.45

14.53

2.6

3.5

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

257

2.74

14.31

1.2

1.6

544.92

700.25

mu/l

0.27

245

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

107

453

2.28

14.23

1.5

1.2

2.95

3.89

umol/l

2.08

417

(3020717) Zinc [Moles/volume] in Serum or Plasma

132

609

2.10

14.20

1.5

1.4

18.68

27.26

umol/l

3.28

126

577

(3024891) Influenza virus A+B Ag [Presence] in Specimen

513

3433

1.45

14.17

1.3

1.1

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

171

3.16

14.11

1.3

1.7

—

(3032057) Clostridioides difficile [Presence] in Stool

292

2.61

14.09

1.9

1.7

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

641

4474

1.39

14.00

1.6

0.46

10.43

iu/ml

1.43

141

996

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

342

2109

1.57

13.97

1.1

567.87

1270.07

iu/ml

0.37

416

(3033705) Calcium.ionized [Moles/volume] in Venous blood

319

1936

1.60

13.95

2.9

2.3

—

(3002079) Sodium [Moles/time] in 24 hour Urine

136

639

2.06

13.94

1.2

154.57

159.21

mmol/24h

0.27

136

639

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

241

1363

1.71

13.87

2.9

2.8

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

273

1600

1.65

13.75

3.3

3.9

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

383

2.37

13.67

3.3

2.1

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

383

2.37

13.67

3.3

2.1

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

287

2.59

13.52

1.1

0.90

0.65

umol/24h

0.58

136

(3000012) Reticulocyte production index

332

2051

1.57

13.48

1.7

2.2

—

(3037756) Immunofixation for Serum or Plasma

478

3188

1.46

13.47

1.5

1.7

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

137

655

2.02

13.42

3.8

3.9

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

166

851

1.89

13.28

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

202

1102

1.77

13.23

1.0

1.1

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

143

699

1.98

13.17

1.6

7.57

9.77

ug/l

1.12

131

636

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

137

660

2.01

13.15

1.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

191

1028

1.80

13.09

1.2

1.3

0.81

1.49

u/ml

0.68

114

560

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

113

508

2.15

13.03

2.2

52.06

50.19

umol/l

0.23

100

430

(3014051) Protein [Presence] in Urine by Test strip

576

3998

1.40

13.03

2.7

2.5

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

108

477

2.19

13.02

1.1

1.2

—

(3039443) Prostate specific Ag panel - Serum or Plasma

134

2464

0.52

12.94

1.5

1.6

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

139

678

1.98

12.89

1.5

1.6

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

175

927

1.83

12.66

1.1

33.44

44.54

mg/l

3.95

143

798

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

266

1589

1.62

12.47

1.5

1.4

0.33

0.37

nmol/l

0.40

195

1208

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

200

1108

1.75

12.45

1.1

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

294

2.50

12.41

1.5

1.2

138.17

128.03

nmol/l

0.21

224

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

137

675

1.96

12.37

1.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

301

1856

1.57

12.36

1.1

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

496

3389

1.42

12.30

1.5

1.6

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

129

626

1.99

12.17

1.0

1.1

1.12

1.08

u/l

0.26

288

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

533

3696

1.40

12.15

1.8

3.77

12.65

iu/l

0.82

190

1344

(3017354) Segmented neutrophils/100 leukocytes in Blood

255

1520

1.62

12.08

3.0

3.4

56.55

57.09

0.16

208

1296

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

16971

159597

1.15

12.07

5.6

4.8

2.66

2.81

mmol/l

87.91

15475

147421

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

190

2.85

11.83

1.0

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

167

892

1.81

11.79

1.1

257.78

273.63

mg/l

0.33

141

801

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

374

2.27

11.69

1.1

1.3

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

165

882

1.81

11.63

1.6

1.4

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

535

3742

1.39

11.61

1.2

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

146

757

1.86

11.36

1.7

1.5

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

131

656

1.93

11.33

1.8

1.5

—

(3011048) Pyruvate [Moles/volume] in Blood

5.16

11.20

1.5

1.2

78.33

71.08

umol/l

0.39

(43055514) Macroprolactin [Presence] in Serum or Plasma

196

2.76

11.19

1.3

1.6

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

218

3372

0.62

11.18

1.4

1.5

—

(3045424) Erythrocytes [Presence] in Urine

388

2585

1.46

11.08

1.5

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

145

763

1.84

10.79

1.7

1.5

—

(3011412) CD3 cells [#/volume] in Blood

229

1370

1.62

10.75

1.8

2.3

1.39

1.20

e9/l

1.31

204

1253

(3039162) Centromere protein B Ab [Units/volume] in Serum

300

1910

1.52

10.74

1.2

68.52

60.33

u/ml

0.17

142

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

568

4064

1.36

10.74

1.4

1.3

—

(3004451) EKG impression Narrative

135

696

1.87

10.72

1.2

1.3

—

(3044927) Protein electrophoresis panel - Urine

242

1469

1.59

10.70

1.2

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

212

2.64

10.68

1.9

1.8

135.11

59.84

pmol/l

0.52

176

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

334

2.28

10.67

1.2

328.06

309.49

pmol/l

0.12

241

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

382

2.17

10.33

1.2

24.13

24.06

0.00

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

172

967

1.72

10.26

1.1

1.3

91.50

88.78

u/l

0.12

151

840

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

168

940

1.73

10.20

1.1

1.3

27.19

22.35

u/l

0.45

142

804

(3038026) Centromere Ab [Units/volume] in Serum

202

1190

1.64

10.12

1.2

54.76

43.93

u/ml

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

249

1543

1.56

10.11

1.7

1.6

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

186

1073

1.68

10.10

1.6

1.9

8.46

10.07

umol/l

0.33

127

788

(3018851) Theophylline [Moles/volume] in Serum or Plasma

113

3.24

10.09

1.8

52.45

47.47

umol/l

0.28

113

(3006922) Hepatitis E virus Ab [Presence] in Serum

171

966

1.71

10.04

1.1

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

197

1158

1.65

9.96

1.2

71.33

74.53

u/ml

0.05

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

117

591

1.91

9.92

1.6

2.2

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

117

591

1.91

9.92

1.6

2.2

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

235

1444

1.57

9.91

1.4

182046.44

95225.52

e6/l

0.91

169

961

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

176

1006

1.69

9.90

1.1

1.0

295.68

585.72

mg/l

0.49

159

904

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

118

599

1.90

9.87

1.6

2.2

—

(3030313) Adrenal Ab [Titer] in Serum

3.42

9.80

1.1

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

197

1164

1.64

9.77

1.2

43.63

45.38

u/ml

0.04

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

178

1025

1.68

9.75

1.2

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

137

733

1.81

9.72

1.5

1.4

1.26

1.17

nmol/l

0.38

101

590

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

218

1325

1.59

9.64

2.5

1.9

2.79

2.35

u/field

0.37

515

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

273

1751

1.51

9.50

3.0

3.3

4.09

9.65

nmol/l

1.05

261

1699

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

178

1033

1.67

9.48

2.7

3.5

92.65

151.63

nmol/l

2.85

173

1022

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

191

1130

1.63

9.44

1.2

—

(40768800) Prostate Pathology biopsy report

169

2659

0.61

9.39

1.2

—

(3036489) Thrombin time

712

5365

1.29

9.38

1.8

2.0

21.47

21.61

0.15

598

4683

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

158

893

1.71

9.30

1.1

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

142

779

1.76

9.28

1.5

2.0

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

142

780

1.76

9.24

1.5

2.0

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

187

1107

1.63

9.23

1.2

2.17

7.81

u/ml

1.24

(3008116) Ketones [Moles/volume] in Urine by Test strip

247

2.38

9.15

1.7

1.3

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

158

899

1.70

9.08

1.1

—

(3024263) Appearance of Synovial fluid

143

794

1.74

8.98

1.4

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

227

1419

1.55

8.93

1.2

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

351

2.12

8.74

1.0

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

207

2.47

8.61

1.0

1.3

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

456

3270

1.35

8.59

1.4

1.5

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

15946

150074

1.11

8.55

4.4

3.9

1.47

1.26

mmol/l

166.84

14404

137662

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

9.11

8.53

1.1

1.2

—

mmol/l

—

(3050129) First trimester maternal screen panel - Serum or Plasma

142

2261

0.60

8.35

1.4

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

168

997

1.63

8.27

1.5

1.6

7.51

6.87

u/l

0.21

131

806

(40759836) Histone Ab [Presence] in Serum by Immunoblot

184

1118

1.59

8.23

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

185

1126

1.59

8.21

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

185

1126

1.59

8.21

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

184

1119

1.59

8.20

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

185

1127

1.59

8.18

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

183

1119

1.58

7.98

1.2

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

16592

156627

1.12

7.98

5.0

4.3

4.57

4.75

mmol/l

98.50

15201

145364

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

147

855

1.66

7.85

2.2

1.7

2.25

2.74

u/field

0.42

104

581

(37021550) Renin [Units/volume] in Plasma --upright

296

2.15

7.85

1.2

1.3

48.43

63.42

mu/l

0.68

214

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

119

1948

0.59

7.84

1.4

1.5

—

(3003338) MCHC [Mass/volume]

13403

132949

0.92

7.82

27.3

16.7

331.07

331.87

g/l

19.80

13289

131943

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

242

1581

1.48

7.79

1.1

1.32

2.51

iu/ml

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

348

2.05

7.79

1.2

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

159

949

1.62

7.69

1.9

2.4

574.23

554.28

e6/l

0.13

131

817

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

194

1214

1.55

7.67

1.1

1.3

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

426

1.93

7.50

1.1

1.2

112.86

113.01

0.02

382

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

136

2.70

7.40

1.1

1.88

1.67

umol/24h

0.57

136

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

164

996

1.59

7.40

1.5

1.9

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

311

2152

1.40

7.37

1.2

1.1

11.47

11.92

au/ml

0.05

123

(3035947) Staphylolysin Ab [Units/volume] in Serum

119

667

1.72

7.32

1.2

1.1

5.57

3.93

iu/ml

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

234

1539

1.47

7.32

1.5

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

234

1539

1.47

7.32

1.5

—

(3010503) CD19 cells [#/volume] in Blood

150

895

1.62

7.29

2.1

2.5

0.53

0.43

e9/l

0.14

143

874

(3001186) Copper [Moles/volume] in Serum or Plasma

275

2.14

7.20

1.3

16.72

16.99

umol/l

0.17

245

(3051593) INR in Capillary blood by Coagulation assay

120

679

1.71

7.15

8.1

12.1

—

(3002619) Bacteria identified in Specimen by Culture

264

2.16

7.10

1.3

1.2

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

107

2.88

7.08

1.4

1.2

9.58

20.70

pmol/l

1.26

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

3.26

7.03

1.6

1.5

3.43

1.94

mg/l

0.32

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

3.26

7.03

1.6

1.5

4.04

4.40

mg/l

0.10

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

3.26

7.03

1.6

1.5

2.25

1.37

mg/l

0.19

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

3.26

7.03

1.6

1.5

1.16

1.85

mg/l

—

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

3.26

7.03

1.6

1.5

2.60

0.59

mg/l

0.50

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

3.26

7.03

1.6

1.5

0.55

1.59

mg/l

0.72

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

3.26

7.03

1.6

1.5

1.42

2.79

mg/l

0.72

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

3.26

7.03

1.6

1.5

2.62

2.21

mg/l

0.09

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

3.26

7.03

1.6

1.5

1.25

1.32

mg/l

0.04

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

279

1917

1.41

6.92

1.1

1.51

1.52

g/l

0.03

253

1739

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

455

1.85

6.79

1.1

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

13.26

6.73

1.3

1.0

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

295

2058

1.39

6.71

1.1

—

(3020491) Glucose [Moles/volume] in Blood

164

1021

1.55

6.70

2.1

1.8

7.36

6.76

mmol/l

1.65

115

694

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

396

1.90

6.67

1.7

1.6

0.38

ug/l

0.01

255

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

3.13

6.63

1.6

0.69

1.77

mg/l

1.22

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

106

2.82

6.61

2.3

1.11

0.84

mmol/l

0.19

(3012494) Peanut IgE Ab [Units/volume] in Serum

307

2.01

6.46

1.0

0.47

1.26

u/ml

0.97

150

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

642

5014

1.24

6.39

2.7

2.9

0.37

0.35

u/ml

0.49

389

2875

(44813793) Dust mix specific IgE antibody measurement

160

1002

1.54

6.39

1.1

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

1487

12526

1.16

6.38

2.8

2.6

66.51

64.31

ml/min/173m2

1.28

621

4941

(3036670) Protein [Mass/volume] in Synovial fluid

451

1.82

6.36

1.3

39.79

40.19

g/l

0.08

240

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

150

927

1.56

6.35

2.0

2.5

0.23

0.24

e9/l

0.10

129

820

(42529582) MDA5 Ab [Presence] in Serum by Line blot

349

1.94

6.34

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

349

1.94

6.34

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

349

1.94

6.34

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

349

1.94

6.34

1.1

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

130

777

1.62

6.34

2.4

2.7

738.09

1237.86

u/ml

3.52

130

770

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

466

1.80

6.32

1.1

1.2

0.32

0.31

g/l

0.46

381

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

16431

155449

1.10

6.25

5.0

4.3

1.42

1.51

mmol/l

135.70

14968

143660

(3047007) Chlamydophila sp Ab [Presence] in Serum

292

2064

1.37

6.17

1.3

1.2

—

(1175426) CD3 cells/100 lymphocytes in Blood

168

1073

1.51

6.15

1.5

1.9

72.86

71.95

0.35

160

1039

(3029075) Extractable nuclear Ab panel - Serum

388

1.87

6.10

1.1

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

295

2.00

6.05

3.1

2.3

7.23

7.79

mmol/l

0.44

166

(4034850) Laboratory test

655

5160

1.23

6.04

13.4

9.1

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

438

1.81

6.03

1.4

61.22

55.34

0.66

370

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

540

4169

1.25

5.99

2.5

3.90

3.60

g/l

3.89

510

3972

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

107

2.70

5.94

1.3

1.1

0.18

0.38

nmol/l

1.52

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

109

634

1.66

5.94

2.3

2.1

158.14

147.19

0.57

103

590

(3020876) Protein [Mass/time] in 24 hour Urine

240

1656

1.40

5.89

2.1

2.5

1.24

1.18

g/24h

0.10

111

814

(21494890) Protein electrophoresis panel - 24 hour Urine

230

1576

1.41

5.87

2.1

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

120

1816

0.63

5.83

1.3

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

121

1827

0.64

5.82

1.3

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

121

1825

0.64

5.79

1.3

1.4

—

(3028433) Virus identified in Specimen by Culture

451

1.78

5.79

1.2

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

788

0.45

5.78

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

787

0.45

5.76

1.3

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

121

1820

0.64

5.72

1.3

1.4

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1007

8307

1.18

5.69

1.6

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

2240

23809

0.89

5.64

2.9

3.0

0.63

0.78

ug/l

14.83

1487

15655

(3043238) Trisomy 21 risk [Likelihood] in Fetus

100

1560

0.62

5.57

1.3

1.5

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

141

888

1.53

5.55

1.1

11.94

9.33

iu/ml

0.25

208

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

123

751

1.58

5.55

1.6

2.0

101.06

98.55

0.31

117

701

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

258

1822

1.37

5.53

1.9

32.29

21.89

ug/l

1.02

248

1781

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

440

1.76

5.38

1.1

117.85

107.76

1.39

399

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

148

949

1.51

5.38

1.4

12.79

umol/l

0.00

138

906

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

134

841

1.54

5.38

1.1

76.69

89.32

u/l

1.21

124

759

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

134

841

1.54

5.38

1.1

19.92

28.45

u/l

1.24

123

759

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

102

2.65

5.36

1.1

7.57

11.73

u/l

0.79

102

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

109

653

1.61

5.34

1.1

2.54

6.57

u/ml

1.78

100

(3051387) C reactive protein [Mass/volume] in Capillary blood

448

3435

1.26

5.32

5.1

3.2

24.14

26.79

mg/l

0.86

286

2215

(3034988) Calcium [Moles/volume] in Capillary blood

257

1.99

5.27

1.8

1.18

mmol/l

0.05

248

(3051651) Icteric interference index of Serum or Plasma

139

884

1.52

5.26

3.4

3.7

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

472

3647

1.25

5.25

1.2

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1523

0.62

5.22

1.3

1.4

—

(3035320) C reactive protein [Mass/volume] in Body fluid

158

1034

1.48

5.21

3.1

2.2

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

319

1.88

5.19

1.1

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

533

1.67

5.15

1.1

260.81

548.90

ng/l

0.59

137

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

426

1.74

5.10

1.1

101.15

87.21

2.01

196

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

230

1619

1.37

5.07

1.1

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

435

1.73

5.03

1.1

96.55

87.16

1.68

197

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1508

0.63

5.02

1.6

1.7

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

204

2.08

4.95

1.5

1.6

—

(3036603) Volume of Urine

159

1054

1.46

4.94

1.5

1.6

2086.36

1883.16

1.72

153

1020

(3012565) Volume of 24 hour Urine

118

736

1.55

4.91

1.7

2.2

2069.85

1935.16

0.69

101

653

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

104

630

1.59

4.90

1.1

56.89

8.26

u/ml

—

(3005033) Fetal Nuchal fold Thickness US

100

1511

0.64

4.90

1.3

1.4

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

174

2.16

4.84

1.1

—

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

3.11

4.83

1.1

1.2

378.50

426.35

u/l

0.13

(3004775) Volume in Urine collected for unspecified duration

179

1219

1.42

4.82

2.0

2.3

665.59

663.80

0.02

119

841

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

128

817

1.51

4.80

1.2

1.1

1.12

1.06

ratio

1.35

280

(3023420) DNA double strand Ab [Units/volume] in Serum

231

1643

1.36

4.80

1.4

35.89

33.40

iu/ml

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

112

697

1.55

4.72

1.1

1.2

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

118

744

1.53

4.70

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

324

1.82

4.67

1.2

1.1

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

134

2.30

4.63

2.3

2.1

—

(3024869) Neuronal Ab [Presence] in Serum

223

1.99

4.62

1.1

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

271

1988

1.32

4.60

1.1

128.50

118.89

4.39

238

1795

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

161

1087

1.43

4.57

1.6

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

383

1.74

4.56

1.5

1.3

34.61

38.48

0.37

259

(3026470) Cobalt [Mass/volume] in Blood

149

993

1.45

4.54

1.8

2.0

2.69

3.95

ug/l

2.10

133

913

(3002523) Influenza virus A Ag [Presence] in Specimen

150

2053

0.70

4.49

1.1

—

(3046861) Legionella sp Ag [Presence] in Urine

2.77

4.43

1.3

1.0

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

131

2.28

4.41

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

145

968

1.45

4.39

1.6

1.7

—

(3009015) Lactate [Moles/volume] in Synovial fluid

156

2.16

4.39

1.3

5.21

6.42

mmol/l

0.86

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

2.57

4.39

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

124

805

1.49

4.33

1.3

1.2

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.61

4.33

1.3

1.2

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.74

4.32

1.1

1.5

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

183

2.06

4.30

1.6

1.3

45.25

56.37

0.64

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

5.03

4.30

2.3

1.4

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

266

1967

1.31

4.29

2.2

2.6

292.40

451.39

u/ml

0.27

261

1953

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

305

1.80

4.29

1.2

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

184

2.04

4.24

1.1

—

(3000093) Morphology [Interpretation] in Blood Narrative

198

1406

1.36

4.22

1.1

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

238

1.91

4.20

1.8

1.7

1.18

1.19

mmol/l

0.39

229

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

388

3015

1.24

4.20

4.0

5.7

613.88

1533.61

iu/ml

0.93

494

(3003740) Influenza virus B Ag [Presence] in Specimen

153

2060

0.71

4.19

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

587

1.56

4.18

1.1

1483.77

1497.80

miu/ml

0.05

587

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

122

2.29

4.18

1.0

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

2.75

4.18

1.6

1.8

1.39

1.42

umol/l

0.14

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

595

1.56

4.17

1.0

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

2.82

4.13

1.4

1.6

0.57

0.15

u/l

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

612

1.55

4.13

1.0

1.1

103.54

96.60

1.33

490

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

142

2.17

4.08

2.2

2.0

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

544

4399

1.20

3.99

1.9

2.1

93.96

91.83

1.34

514

4225

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

131

2.21

3.98

1.1

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

1029

0.61

3.98

1.3

1.55

1.57

g/l

0.34

1029

(3006245) CD3-CD19+ cells/100 cells in Blood

496

1.60

3.97

1.4

2.0

10.45

10.52

0.02

453

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

189

1.99

3.97

2.7

2.2

0.62

0.60

u/field

0.04

189

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

114

743

1.48

3.95

2.8

3.3

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

408

1.66

3.93

1.2

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

329

1.73

3.90

1.2

1.1

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.64

3.88

1.2

1.5

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

503

4051

1.20

3.87

2.4

192.43

192.98

0.04

462

3836

(3032743) Legionella sp IgG Ab [Presence] in Serum

2.56

3.85

1.3

1.1

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

145

995

1.41

3.83

2.1

2.6

797.90

673.30

e6/l

1.15

135

961

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

2.97

3.81

1.0

172.87

160.31

pmol/l

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

273

2061

1.28

3.81

1.1

—

(3033942) Copper [Moles/time] in 24 hour Urine

3.21

3.79

1.0

1.2

0.18

0.79

umol/24h

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

282

1.78

3.79

1.2

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

119

790

1.45

3.77

1.2

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

160

2.05

3.76

1.0

1.1

0.11

0.13

u/ml

0.05

111

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

300

2296

1.26

3.75

1.2

1.3

24.09

35.59

u/l

2.22

253

1988

(3028717) Thiamine [Mass/volume] in Blood

116

2.24

3.74

1.3

1.2

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

169

1198

1.36

3.69

1.2

102.50

202.03

titre

1.23

207

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

476

1.58

3.67

1.5

1.9

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

2.50

3.67

1.3

1.1

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

314

1.72

3.65

4.6

5.6

71.05

70.40

0.06

245

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

307

1.73

3.65

1.2

1.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

274

2085

1.27

3.61

1.3

1.2

4.35

4.10

u/ml

0.15

120

934

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

210

1.88

3.59

1.4

1.3

75.01

471.37

ng/l

0.58

152

(3001556) Androgen free Index in Serum or Plasma

2.86

3.59

1.1

1.0

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

305

2354

1.25

3.57

1.2

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

580

1.51

3.55

2.2

2.4

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

164

2.00

3.54

1.2

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

436

1.59

3.52

2.0

1.7

9.21

9.49

mg/l

0.15

351

(3025577) Chromium [Mass/volume] in Blood

140

972

1.39

3.50

1.9

2.0

1.95

2.50

ug/l

1.76

116

816

(3051611) Lipemic interference index of Serum or Plasma

218

1619

1.30

3.49

3.3

3.2

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

470

3804

1.20

3.47

2.6

2.9

1.54

1.59

mg/l

0.52

410

3470

(3044009) aPTT.lupus sensitive (LA screen)

108

2.23

3.44

1.1

1.2

—

(3013336) Amino acids [Identifier] in Serum or Plasma

9.64

3.41

3.2

2.2

—

(3041806) Other cells [#/volume] in Blood by Manual count

160

1.99

3.40

1.7

1.4

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

125

1674

0.72

3.40

1.3

1.5

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

187

1.91

3.39

1.3

185720.46

272735.34

nmol/l

0.15

154

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

2.59

3.39

1.8

1.5

24.34

23.17

mmol/l

0.31

(3003694) ABO and Rh group [Type] in Blood

4080

41389

0.94

3.36

1.4

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

2.51

3.36

1.2

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

449

1.57

3.36

2.6

3.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

657

7290

0.86

3.35

1.9

1.7

—

(3016750) Collection duration of Urine

126

867

1.40

3.34

1.9

2.2

520.05

494.87

min

1.71

674

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

203

1.85

3.28

1.7

2.6

61.20

69.47

pmol/l

0.34

178

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

568

1.50

3.27

1.1

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

3.93

3.26

1.2

1.3

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1133

12115

0.90

3.24

1.4

1.3

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1196

0.68

3.24

1.3

1.5

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

454

1.55

3.22

1.2

1.1

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

307

1.67

3.13

1.3

1.2

0.81

45.74

mg/l

1.17

229

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

179

1.89

3.12

1.2

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

277

2152

1.24

3.12

1.3

1.2

3.96

3.82

u/ml

0.04

735

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

528

1.50

3.10

1.1

—

(3050794) Legionella sp Ab [Presence] in Serum

101

2.20

3.07

1.3

1.1

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

331

2627

1.22

3.05

1.2

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

324

1.64

3.05

1.2

1.1

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

2.44

3.04

1.1

1.0

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

216

1.79

3.02

1.1

1.0

0.55

1.72

u/ml

0.45

177

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

190

1416

1.30

3.02

3.8

5.1

135.14

144.95

u/ml

0.05

459

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

290

2274

1.23

3.01

2.2

2.7

1318.94

5182.54

u/ml

0.52

146

(3037692) Legionella sp identified in Specimen by Organism specific culture

540

1.48

3.00

1.2

1.4

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

5.62

2.93

1.0

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

470

0.51

2.93

1.5

—

(3001729) Color of Synovial fluid

117

2.06

2.87

1.4

1.7

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

308

2447

1.22

2.84

1.2

1.3

270.64

286.39

u/ml

0.52

194

1585

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

399

1.55

2.84

2.2

2.4

170.25

130.10

au/ml

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

430

1.53

2.83

2.6

3.0

9.57

7.54

mg/l

0.83

354

(3027035) Albumin [Mass/time] in 24 hour Urine

131

1.99

2.82

1.5

1.3

61.50

325.62

mg/24h

—

(3006576) Bicarbonate [Moles/volume] in Blood

494

1.48

2.78

5.5

6.6

25.39

25.16

mmol/l

0.17

443

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

424

1.52

2.78

1.3

1.7

9.68

8.85

ug/l

0.79

424

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

137

988

1.34

2.78

1.8

—

(3052592) Norovirus Ag [Presence] in Stool

303

1.62

2.77

1.2

1.4

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

355

1.55

2.57

1.7

1.5

98.11

154.72

au/ml

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

171

1.80

2.55

1.2

—

(21494814) CD8 cells/100 lymphocytes in Specimen

584

1.42

2.55

1.6

1.9

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

196

1506

1.26

2.51

1.1

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

104

2.04

2.49

1.0

1.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

578

4897

1.14

2.49

1.6

1.7

4.00

3.83

mg/l

0.14

486

3493

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

223

1.69

2.48

1.8

2.6

58.00

81.53

mg/l

0.27

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

2.16

2.47

2.3

1.4

6.79

12.93

1.31

(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline

5.26

2.47

1.2

1.1

277.83

303.27

nmol/l

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1913

17231

1.08

2.46

3.0

4.1

21.40

27.04

ug/l

0.38

1549

13915

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

402

3320

1.17

2.46

2.7

3.5

541.32

1007.17

u/ml

0.69

365

3033

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

2.20

2.45

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

310

2505

1.20

2.45

1.6

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

174

1.77

2.42

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

253

2009

1.22

2.41

1.1

0.45

0.91

u/ml

2.54

124

747

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

140

1.86

2.38

1.1

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

2.21

2.36

1.1

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

4.82

2.33

1.8

2.0

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

2.05

2.32

2.3

1.4

52.07

35.95

0.90

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

341

2796

1.18

2.30

1.3

1.4

20.87

22.65

u/ml

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

2816

25760

1.06

2.30

1.4

—

(3009542) Hematocrit [Volume Fraction] of Blood

18253

174668

1.07

2.29

30.4

19.2

39.41

40.18

18.84

17006

163159

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

343

2816

1.18

2.28

1.3

1.4

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

2.24

2.28

1.0

0.26

0.03

u/ml

—

(3023199) Leukocytes [#/volume] in Pleural fluid

228

1808

1.22

2.23

1.4

1.5

6311.04

2134.80

e6/l

0.52

167

1296

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

306

1.54

2.23

1.4

1.1

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

3.10

2.21

1.1

1.2

1.78

2.57

—

(3003434) Protein [Mass/volume] in Pleural fluid

253

2032

1.20

2.18

1.4

1.5

32.83

32.82

g/l

0.00

228

1825

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

308

1.53

2.17

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

260

2095

1.20

2.16

1.1

2.91

3.84

u/ml

0.65

147

943

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

238

1904

1.21

2.14

1.0

1.1

2.26

3.53

u/ml

1.83

896

(3028308) Erythrocytes [#/volume] in Pleural fluid

208

1643

1.22

2.13

1.4

1.5

39586.71

44885.50

e6/l

0.19

126

949

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

226

1.62

2.13

1.5

1.6

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

110

806

1.32

2.10

2.1

2.9

42.06

38.06

1.52

466

(3033086) Enterovirus NOS Ab [Titer] in Serum

2.68

2.03

1.1

1.0

—

(3007542) Rye IgE Ab [Units/volume] in Serum

2.32

2.03

1.0

1.07

0.69

u/ml

—

(3006462) Nitrate [Presence] in Urine

102

745

1.32

2.00

3.9

3.3

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

308

2539

1.17

2.00

1.3

1.5

108.90

117.20

u/ml

0.89

589

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

104

763

1.32

1.98

1.1

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

114

1.86

1.98

1.0

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

186

1.66

1.97

1.3

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

2.21

1.97

1.0

0.23

0.01

u/ml

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

285

2338

1.18

1.97

1.1

0.99

1.90

u/ml

2.11

163

1075

(4035726) Immunohistochemistry procedure

1437

14822

0.93

1.97

1.3

1.4

—

(3017704) Immunofixation for Urine

113

843

1.29

1.92

1.3

1.7

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

176

1384

1.23

1.92

1.3

777.84

476.21

u/l

0.53

165

1316

(3007461) Platelets [#/volume] in Blood

18257

174837

1.07

1.91

30.4

19.2

258.85

251.95

e9/l

36.36

17853

169876

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

335

1.47

1.88

1.1

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

3.61

1.86

1.0

1.1

—

(3038205) Alternaria alternata IgE Ab [Units/volume] in Serum

2.41

1.86

1.0

0.08

0.11

u/ml

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

522

1.37

1.85

2.0

1.9

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

175

1.65

1.84

1.1

1.2

—

(3002256) Pathology report gross observation

2298

21048

1.06

1.83

1.3

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

698

1.31

1.82

2.2

2.1

433.94

76.34

ug/min

0.51

158

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

3280

32918

0.95

1.82

4.3

4.2

21.10

22.03

2.65

1410

16239

(4281824) Cell count and differential, peritoneal fluid

177

2065

0.82

1.81

1.2

1.1

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

154

1.69

1.80

2.6

3.0

1.71

1.14

mg/l

0.83

103

(3019174) dRVVT (LA screen)

111

1.82

1.80

1.1

1.2

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

3.07

1.80

1.0

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

509

1.36

1.79

1.3

1.7

109809.57

25790.69

u/ml

0.41

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

387

1.42

1.79

1.0

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

359

3026

1.15

1.77

3.2

3.0

0.82

0.81

nmol/l

0.11

269

2360

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

132

0.36

1.74

1.0

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

270

1.50

1.74

1.2

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.93

1.72

1.1

—

(3000060) B lymphocytes [#/volume] in Blood

334

1.44

1.72

1.2

1.9

195.38

718.40

e6/l

1.25

175

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

2.01

1.69

1.2

1.3

—

(3010813) Leukocytes [#/volume] in Blood

18264

174987

1.06

1.69

30.4

19.2

6.97

6.62

e9/l

73.27

17815

169474

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

147

1153

1.23

1.68

1.2

1.3

9.98

8.70

mmol/l

2.31

138

1101

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

100

1.83

1.67

1.3

1.2

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

188

1.59

1.66

1.1

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

593

1.32

1.63

1.2

5.0

66.60

2058.75

mg/l

1.85

427

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

152

1.65

1.61

1.1

—

(3035941) MCH [Entitic mass]

18257

174955

1.06

1.60

30.2

19.1

30.26

30.29

1.34

17988

172311

(3024731) MCV [Entitic volume]

18259

174976

1.06

1.59

30.2

19.1

91.28

91.08

7.12

17990

172327

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

102

1.80

1.58

1.6

1.5

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

2.49

1.58

1.0

—

(3026361) Erythrocytes [#/volume] in Blood

18259

174991

1.06

1.56

30.3

19.2

4.41

4.48

e12/l

70.92

17810

169517

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

531

1.33

1.55

1.3

1.4

57.61

64.39

0.93

436

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

2.59

1.51

4.4

5.9

0.31

0.25

mmol/l

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

183

1487

1.19

1.50

1.2

1.1

93.24

95.43

0.50

163

1385

(3020393) Adenovirus Ag [Presence] in Stool

126

1.68

1.49

1.0

1.1

—

(3042733) HLA Ab [Presence] in Serum

506

0.69

1.48

4.8

5.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

313

1.42

1.47

1.1

—

(3045142) Bone marrow Pathology biopsy report

150

1735

0.83

1.47

1.3

—

(3000963) Hemoglobin [Mass/volume] in Blood

18260

175045

1.05

1.45

30.5

19.3

132.57

134.96

g/l

97.26

18004

172410

(3012441) Differential panel - Pleural fluid

187

1528

1.18

1.44

1.5

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

2.34

1.44

1.1

1.0

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.28

1.41

1.0

—

(3051101) Glucose [Moles/volume] in Cord blood

292

1.42

1.41

4.8

5.9

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

686

1.27

1.38

1.3

1.2

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

107

1.71

1.37

2.5

1.9

22.64

22.12

mg/l

0.06

(3046904) Somatotropin [Units/volume] in Serum or Plasma

2.63

1.37

2.3

2.8

1.87

2.17

mu/l

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

116

0.42

1.37

1.0

1.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

619

1.28

1.36

2.5

2.9

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

270

1.43

1.36

1.1

2.01

9.61

pmol/l

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

225

1878

1.16

1.35

1.1

0.62

1.29

u/ml

2.72

129

844

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

0.00

1.34

0.0

1.4

—

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

1.87

1.34

1.9

1.3

1.11

1.83

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

410

1.34

1.4

29.81

19.05

1.82

369

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

174

1428

1.18

1.31

2.4

2.2

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

701

1.25

1.30

1.2

1.5

—

(3036782) Glucose [Moles/volume] in Pleural fluid

171

1404

1.18

1.28

1.3

1.4

6.42

6.31

mmol/l

0.17

157

1294

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

546

0.72

1.28

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

397

1.34

1.28

1.8

1.9

—

(3047189) Immunofixation for 24 hour Urine

703

1.25

1.27

1.6

1.9

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

618

1.26

1.2

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

103

1.68

1.25

2.6

1.9

—

(3052912) Proteinase 3 IgG Ab [Units/volume] in Serum

2.41

1.24

1.0

—

45.54

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

187

1552

1.16

1.24

1.3

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

187

1554

1.16

1.22

1.1

4.36

3.07

u/ml

0.37

580

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

157

1.54

1.22

1.0

1.1

22.24

19.42

u/l

0.27

105

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.96

1.21

1.2

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

435

1.31

1.20

1.2

1.1

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

2.14

1.20

1.3

1.0

—

(3008607) Semen analysis panel

2.14

1.20

1.1

1.2

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

701

1.24

1.19

1.2

1.5

—

(3009871) Measles virus Ab [Titer] in Serum

571

0.74

1.19

1.7

1.6

—

(3020874) Milk IgE Ab [Units/volume] in Serum

763

1.23

1.17

1.0

1.1

0.64

1.60

u/ml

0.98

221

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

2.08

1.17

1.0

1.3

1.50

1.33

—

(4094501) Cardiovascular stress test using bicycle ergometer

477

4210

1.09

1.16

1.1

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

281

3034

0.89

1.15

3.2

3.4

31.49

40.62

u/ml

0.95

273

2930

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

288

1.37

1.15

1.2

103.44

87.35

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

0.00

1.15

0.0

1.3

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

783

1.22

1.14

1.0

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

2.03

1.13

1.1

—

(3035880) pH of Pleural fluid

102

812

1.21

1.11

1.3

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

241

1.40

1.11

1.1

1.3

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

734

1.22

1.11

2.8

2.2

198.51

207.62

u/l

0.65

727

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

201

1.44

1.10

1.0

1.1

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

2.41

1.10

1.4

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

466

4124

1.09

1.08

1.3

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

2.18

1.07

1.0

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

660

5928

1.08

1.07

2.7

3.5

438.68

1785.04

u/ml

1.88

557

5060

(3000034) Microalbumin [Mass/volume] in Urine

175

1467

1.15

1.06

3.2

3.0

16.50

51.20

mg/l

3.71

125

1014

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

293

1.35

1.06

1.1

1.2

98.67

72.36

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

553

4937

1.08

1.05

1.4

1.5

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

465

4865

0.92

1.04

1.9

1.8

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.66

1.02

1.3

1.1

—

(40768806) Pleura Pathology biopsy report

185

1563

1.14

1.01

1.5

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

103

1.59

0.99

1.0

1.1

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

399

1.28

0.97

1.3

45.24

233.45

ug/l

1.92

224

(3032352) Blasts [#/volume] in Cerebral spinal fluid

127

1.52

0.97

1.5

2.1

—

(3023383) Lactate [Moles/volume] in Pleural fluid

469

1.25

0.95

1.2

1.3

4.15

3.22

mmol/l

1.04

434

(3045788) Cell count panel - Pleural fluid

166

1403

1.14

0.93

1.5

—

(40757373) Influenza virus identified in Isolate

284

1.32

0.92

1.6

1.5

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

137

1.48

0.91

1.4

1.7

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

200

1714

1.13

0.91

1.1

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

114

1.52

0.89

1.2

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

548

5650

0.93

0.88

1.4

1.3

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

1.84

0.86

1.0

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

414

3697

1.08

0.84

1.2

1.3

174.77

216.47

miu/ml

1.80

149

1707

(3001893) Eosinophils/100 leukocytes in Pleural fluid

452

1.24

0.83

1.3

1.4

1.58

2.67

1.09

379

(3011335) Digoxin [Mass/volume] in Serum or Plasma

132

0.58

0.83

1.9

2.2

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

193

1665

1.12

0.81

1.1

1.0

2.62

3.28

u/ml

0.33

106

728

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

359

1.26

0.81

1.1

1.3

—

(3025130) Human papilloma virus identified in Specimen

221

1925

1.11

0.79

1.8

1.7

—

(1617658) Protocol used for examination of sentinel lymph nodes

128

1407

0.88

0.78

1.0

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

392

0.76

0.78

1.3

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

130

1099

1.14

0.77

1.3

16.82

13.45

u/l

0.46

120

1004

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

354

1.25

0.75

2.3

2.4

—

(3041672) Baker's yeast Ab [Presence] in Serum

1.70

0.75

1.0

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

529

1.20

0.75

1.1

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

190

0.66

0.75

13.1

7.0

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

365

1.24

0.72

1.3

1.4

31.23

22.18

0.97

299

(40761995) Spermatozoa Progressive [#/volume] in Semen

165

0.64

0.72

1.9

2.9

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

164

0.65

0.70

3.8

5.8

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

243

0.71

0.70

3.8

5.3

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

898

0.86

0.68

1.1

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

936

9402

0.96

0.66

3.0

3.7

97.46

57.38

u/ml

0.59

898

9104

(3015183) Erythrocyte sedimentation rate

708

0.84

0.66

1.2

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

423

1.21

0.65

1.9

66.63

35.93

u/l

0.45

389

(21494434) Karyotype in Bone marrow

151

1306

1.11

0.65

1.1

1.2

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

141

1.37

0.62

1.2

1.1

—

(3006567) Chloride [Moles/time] in 24 hour Urine

1.66

0.61

1.2

1.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

150

1.35

0.61

1.2

—

(3022689) Creatine [Moles/volume] in Urine

480

1.18

0.61

1.3

1.5

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

235

1.27

0.60

1.3

1.2

1.65

1.68

mmol/l

0.01

150

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

132

0.66

0.60

1.1

1.0

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

109

1.41

0.60

3.9

5.0

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.60

0.0

1.1

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.59

0.0

1.0

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

145

1262

1.11

0.58

1.8

3.60

4.02

mg/l

0.88

135

1214

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

108

0.62

0.58

1.0

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

430

1.19

0.57

1.3

1.4

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

183

1615

1.09

0.56

1.1

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

290

1.23

0.56

1.2

1.49

1.73

mmol/l

0.78

180

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

119

1027

1.12

0.56

5.5

6.4

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

1.65

0.56

9.3

9.2

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

1.65

0.56

1.2

1.1

—

(3024932) HLA-DR beta [Type]

508

0.83

0.55

1.2

1.1

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

352

1.20

0.55

1.3

26.40

26.73

g/l

0.04

279

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

103

1.40

0.55

1.1

8.26

8.54

mmol/l

0.22

103

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

1.61

0.55

1.0

197.83

237.53

u/l

—

(3032868) Hemoglobin electrophoresis panel in Blood

121

0.64

0.54

1.1

1.6

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

101

867

1.12

0.53

1.1

—

(3010375) cycloSPORINE [Mass/volume] in Blood

681

0.86

0.53

27.6

28.3

111.00

112.90

ug/l

0.07

587

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.45

0.52

1.0

1.5

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

1.42

0.52

1.1

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

671

1.14

0.50

1.0

0.41

0.85

u/ml

0.35

140

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

216

0.76

0.49

1.9

—

(3034426) Prothrombin time (PT)

492

1.16

0.48

1.3

1.2

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

123

1.33

0.48

2.4

2.6

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

140

1.31

0.48

1.1

1.0

—

(3013293) Extractable nuclear Ab [Presence] in Serum

237

1.22

0.45

1.5

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.38

0.44

1.0

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.39

0.44

1.0

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

117

1235

0.91

0.43

1.2

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

135

0.71

0.43

1.2

—

(40768441) Liver Pathology biopsy report

127

1123

1.09

0.42

1.3

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

135

1.29

0.41

1.1

1.0

—

(3008536) Aspergillus sp Ab [Presence] in Serum

311

1.18

0.41

1.8

2.1

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.41

0.0

1.0

—

(40763629) HC gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.00

0.41

0.0

1.1

—

(40760409) HLA-A [Type] by High resolution

1.35

0.40

1.0

—

(40760410) HLA-B [Type] by High resolution

1.35

0.40

1.0

—

(46236302) HLA-C [Type] by High resolution typing

1.35

0.40

1.0

—

(40763590) HLA-DQ beta [Type]

1.35

0.40

1.0

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

4310

41032

1.02

0.40

4.8

2.17

3.39

ug/l

5.09

3768

37027

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.42

0.40

13.2

7.2

—

(40768795) Lymph node Pathology biopsy report

165

1704

0.93

0.38

1.2

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

216

1.20

0.37

3.3

4.9

48.59

42.04

ug/min

0.21

167

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.34

0.37

1.2

1.0

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

182

1.22

0.36

1.0

99.35

79.92

ug/l

1.27

140

(40762814) Titanium [Mass/volume] in Blood

290

1.16

0.34

2.1

2.3

3.45

4.05

ug/l

0.39

101

(3014891) Appearance of Pleural fluid

201

1.20

0.34

1.3

1.2

—

(3013762) Body weight Measured

1.31

0.33

1.2

1.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

145

1493

0.94

0.33

2.2

2.4

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

140

1.24

0.33

1.1

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

750

1.09

0.32

1.0

0.66

1.59

u/ml

0.55

153

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.32

0.31

1.0

1.6

—

(3005011) Chlamydia sp Ab [Titer] in Serum

168

1.20

0.30

1.9

1.6

—

(3024471) HLA-A [Type]

518

0.89

0.30

1.0

—

(3013862) HLA-DP [Type]

1.28

0.28

1.0

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.26

0.27

1.0

1.1

356.63

296.77

nmol/l

—

(3020650) Glucose [Presence] in Urine

370

1.12

0.27

1.9

1.4

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

214

1968

1.05

0.27

1.3

7.54

7.42

mmol/l

0.26

186

1714

(3011325) HIV 1+2 Ab [Presence] in Serum

0.70

0.26

1.0

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.70

0.26

1.0

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

390

0.89

0.26

1.0

1.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

261

2420

1.04

0.24

1.2

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

327

0.88

0.24

1.6

3.2

107.28

102.28

ng/l

—

116

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.73

0.24

3.3

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

142

1442

0.95

0.24

1.1

1.2

—

(40768446) Kidney Pathology biopsy report

568

0.92

0.23

1.5

1.7

—

(40758292) HTLV I+II Ab panel - Serum

244

0.87

0.22

1.2

1.5

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.75

0.22

1.0

1.2

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

580

1.08

0.22

2.0

1.9

474.52

2719.59

e6/l

0.96

393

(3028468) Fragments [Presence] in Blood by Light microscopy

0.00

0.21

0.0

2.5

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

0.21

0.0

1.1

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.21

0.0

1.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

554

0.92

0.21

1.1

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

0.21

0.0

1.2

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

148

1363

1.05

0.20

1.1

1.0

0.35

0.26

u/ml

0.12

340

(40765089) Chromosome analysis panel - Blood by G-banded

230

0.88

0.19

1.0

—

(40765096) Chromosome analysis panel by Banding

440

0.92

0.18

1.0

1.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

117

0.82

0.18

1.2

1.1

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

1.14

0.17

1.6

1.3

—

(4212803) Bone marrow aspirate examination

133

1.16

0.17

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

348

0.91

0.17

1.0

1.2

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

1.19

0.16

1.0

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

226

1.11

0.16

1.4

8.36

12.31

0.71

112

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

291

1.09

0.16

3.9

5.4

43.33

56.49

u/l

0.88

283

(3045462) Protein/Creatinine [Ratio] in Urine

1.14

0.15

4.2

3.5

74.00

55.85

g/mol

—

(3033799) Differential panel - Peritoneal fluid

494

0.94

0.14

1.7

1.8

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

325

0.92

0.14

1.1

1.8

1.43

3.42

ug/l

1.59

200

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

453

0.94

0.14

1.0

1.2

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

219

1.10

0.14

8.4

10.8

6.62

4.97

mmol/l

0.50

219

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

0.80

0.13

1.0

1.1

—

(3044007) Cell count panel - Peritoneal fluid

462

0.94

0.13

1.9

1.8

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

362

0.93

0.12

1.0

1.2

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

814

1.04

0.12

1.2

1.3

142.12

167.48

pmol/l

1.05

814

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

258

1.08

0.12

1.2

—

(40768793) Breast Pathology biopsy report

422

3999

1.02

0.12

1.3

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

138

1.12

0.11

1.2

98.04

112.01

ug/l

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

391

1.06

0.11

1.5

1.3

11.87

13.56

g/l

0.53

303

(46235168) Fasting glucose [Moles/volume] in Blood

176

1.10

0.10

13.5

1.3

7.78

7.19

mmol/l

0.48

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

515

1.05

0.10

1.9

1.8

2628.84

12592.57

e6/l

1.58

268

(3000285) Sodium [Moles/volume] in Blood

200

0.92

0.10

1.2

1.1

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

150

0.90

0.09

1.1

1.2

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

1.07

0.09

1.0

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.07

0.09

1.0

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

131

1.10

0.08

7.9

5.5

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

1.05

0.08

30.5

14.3

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

1.03

0.08

1.0

1.1

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.78

0.08

1.0

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

416

4057

0.99

0.08

1.5

1.4

176.81

148.64

pmol/l

0.36

407

3969

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

1.09

0.08

1.1

1.0

0.13

1.20

u/ml

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

358

1.05

0.08

1.1

1.0

10.11

8.28

u/ml

0.14

202

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

387

1.05

0.07

9.9

8.3

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

735

0.97

0.07

6.0

4.7

3144.00

7108.72

u/ml

0.26

110

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

272

2585

1.01

0.07

1.8

1.6

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

0.82

0.07

1.0

—

(40758358) Immune stain study

1.04

0.07

1.0

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

166

0.93

0.06

1.1

1.0

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

185

0.94

0.05

1.2

1.0

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

248

1.05

0.05

2.0

3.0

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

403

1.03

0.03

1.4

1.3

29.10

31.74

nmol/l

0.16

361

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

192

0.95

0.03

1.0

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

191

0.96

0.02

1.2

1.4

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

142

0.95

0.02

2.1

2.3

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

151

0.96

0.01

2.7

2.3

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

264

1.02

0.00

5.2

7.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

237

0.98

0.00

1.0

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

237

0.98

0.00

1.0

1.2

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

139

1.04

0.00

1.0

1.2

12.55

9.02

mg/l

0.56

127

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

526

0.99

0.00

1.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

150

0.96

0.00

1.0

1.1

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

1.06

0.00

4.5

5.0

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

467

0.99

0.00

1.7

—

(3026726) Creatinine [Moles/volume] in Specimen

120

1.04

0.00

3.4

2.5

539.77

302.86

umol/l

0.38

114

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

236

0.98

0.00

1.0

1.2

—

(3048879) Bone marrow aspiration report

477

0.99

0.00

1.5

1.9

—

(3035933) Granulocytes/100 leukocytes in Blood

345

1.01

0.00

3.6

1.5

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

337

1.00

0.00

9.7

8.2

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

888

1.00

0.00

1.1

1.2

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

112

1082

1.00

0.00

1.3

1.6

2.44

5.12

ug/l

2.21

844

(3029396) Erythrocyte agglutination [Presence] in Blood

222

1.00

0.00

2.5

2.7

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.0

1.1

—

(3030703) Everolimus [Mass/volume] in Blood

0.00

0.0

21.3

—

5.60

—

(3000219) Insulin receptor Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

0.91

-0.00

1.0

—

(42529039) t(15;17)(q24.1;q21.1)(PML,RARA) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

7.6

—

(3002853) Influenza virus B Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3039542) Porphyrins [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.2

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

-0.00

0.0

6.5

—

(3042951) Complement C1q Ab [Units/volume] in Serum

0.96

-0.00

1.0

1.1

—

22.55

—

(3004560) Lymphocytes [#/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.95

-0.00

1.5

1.3

419.88

312.10

umol/24h

—

(3043614) Bacteria identified in Aspirate by Culture

0.00

-0.00

0.0

1.2

—

(3022475) Manganese [Moles/volume] in Blood

0.96

-0.00

1.6

1.3

—

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.90

-0.00

1.1

8.16

8.83

—

(36031836) Tocilizumab [Mass/volume] in Serum

0.00

-0.00

0.0

1.3

—

19.53

—

(3033463) Neutrophils [#/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3045759) Histamine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.6

—

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.90

-0.00

1.1

21.13

21.89

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

0.90

-0.00

1.1

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: MRI_NONSEL – Non-selective monoamine reuptake inhibitors

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Non-selective monoamine reuptake inhibitors

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Non-selective monoamine reuptake inhibitors (MRI_NONSEL)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints